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The IHCP was established in
October 1998 through the re-
organization of existing exper-
tise and structures within the
JRC Institutes in the area of
health and consumer protec-
tion. On January 15 2002 I had
the pleasure and honour to
take up my duties as Director of
this Institute. The biggest cha-
llenge since then was to position the IHCP as a scientific
reference and validation centre that translates scienti-
fic knowledge into a real support for the policy-makers.
Looking back, I am proud to say that it has taken up this
role in many of its scientific areas. For example the IHCP
has played a central role in the drafting of the new chem-
icals legislation through provision of expertise in risk as-
sessment. Its analysis in 2003 on the additional testing
needs under the new EU Chemicals Policy (REACH) has
lead to increased awareness among Member States and
industry that refined exposure information, cell culture
tests and computer models, such as quantitative struc-
ture activity relationships (QSARS), can lead to a signifi-
cant reduction of direct testing costs, the use of animals
and speed-up the assessment process. The IHCP has also
actively promoted the replacement of laborious and cost-
ly laboratory animal tests for the safety evaluation of
chemicals with modern alternative methods.
Over the last five years the IHCP has combined its efforts
with industry to eliminate existing deficiencies in data
on human exposure to chemicals allowing a more accu-
rate evaluation of the overall risk for European citizens
when exposed to chemicals from various sources (inges-
tion, inhalation, skin contact). In 2003 we produced an
important report on environmental tobacco smoke (ETS)
supporting national legislation to ban smoking in certain
public areas.
Besides chemicals, the IHCP gave substantial support in
the drafting of new EU Regulations on genetically modi-
fied organisms (GMOs) mandating the IHCP to act as the
Community Reference Laboratory (CRL), regulating the
detection, identification and quantification of genetical-
ly modified organisms (GMOs) in food and feed.
The IHCP has actively contributed in shaping the Europe-
an Research Area through extensive networking, such as
the European Network of GMO Laboratories (ENGL) and
training of scientists from the Member States and Acces-
sion Countries.
April 2004
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Foreword
Kees van Leeuwen
IHCP Director
The mission of the IHCP is to provide scientific support
to the development and implementation of EU policies
related to health and consumer protection. The IHCP
carries out research to improve the understanding of
potential health risks posed by chemicals, biocides, ge-
netically modified organisms, contaminants released
from food contact materials and consumer products.
IHCP’s direct end-users are services within the Euro-
pean Commission. Moreover, IHCP collaborates with a
large number of universities, industrial partners, Euro-
IHCP activities focus on the following scientific objec-
tives:
• Validation of methods to detect genetically modified
organisms (GMOs) in food and feed.
• Development and validation of alternative testing
methods to replace, reduce or refine the use of labo-
ratory animals in biomedical sciences.
• Assessment of risks to health and environment from
chemical substances, and management of related in-
formation service.
• Evaluation and quantification of exposure to envi-
ronmental stressors (such as chemicals, biological
contaminants, radiation and noise).
• Development, validation and use of advanced pro-
cessing techniques and test methods for the qualifi-
cation of biocompatible materials, medical devices,
and health diagnostics.
pean and national authorities, international organiza-
tions, and consumer associations (the following is a
non-exhaustive list):
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End-users/Collaborations
Customers (within EC) • DG Agriculture, DG Environment, DG Enterprise, DG Consumer Protection (SAN-
CO), DG Research, DG Trade, DG Taxation and Customs Union (TAXUD), DG Enlarge-
ment, European Anti-Fraud Office (OLAF)
• DG JRC: EI (Ispra), IRMM (Geel), IAM (Petten), ITU (Karlsruhe), IPTS (Seville)
• European Medicine Evaluation Agency (EMEA)
Customers (outside EC) • European Parliament
• International organisations (i.e., OECD, WHO, FAO, Council of Europe, European
Directorate for the Quality of Medicines (EDQM))
• Interagency Committee for the Validation of Alternative Methods (ICCVAM)
• US Environmental Protection Agency
• US Food and Drug Administration
• European agencies - Governments (i.e., Competent authorities responsible for
the implementation of biotechnology and novel food Directives; chemical au-
thorities, pharmaceutical regulatory agencies in the European Economic Area
(EEA), regulatory and health care authorities)
• Non-governmental organisations (NGOs)
• Industry (i.e., biotechnology, food and feeding stuff, chemicals, cosmetics, bio-
medical and pharmaceutical)
• Consumer Organisations
• National Research Institutions and Universities
IHCP Mission Statement Scientific Objectives
In 2003 the IHCP gave significant scientific support to
the drafting of new EU Chemicals legislation (REACH),
which the Commission proposed on October 29th 2003.
In the future it will continue to provide assistance in
the implementation of REACH regarding the develop-
ment of necessary guidance documents, software tools
and infrastructure. This support is based in particular on
the work of the European Chemicals Bureau (ECB) with
respect to data collection, priority setting and risk as-
sessment of existing chemical substances and on its co-
ordinating role of the EU notification scheme and risk
assessment for new chemical substances. In 2003, 400
new substances were notified and 30 risk assessment re-
ports on existing substances were produced. 5 testing
methods were submitted for Annex 5 of Directive 67/
548/EEC, which contains binding EU standardised test-
ing methods to determine hazardous properties of che-
micals. A large part of the ECB’s work in the past few
years is related to the technical and scientific support
needed for the development, introduction and adapta-
tion of testing methods of Annex V to Directive 67/
548/EEC. In 2003 the ECB prepared a list of 250 classi-
fied and labelled substances, which will be part of the
next Adaptation of the Directive 67/548/EEC.
Following an administrative arrangement between DG
TAXUD and the JRC, the ECB is currently carrying out a
feasibility study on the further improvement of the Eu-
ropean Customs Inventory of Chemical Substances
(ECICS), which allows identification of all marketed
chemicals for customs and legal purposes (approx.
28 600 substances). It has established the European
Chemical Substances Information System (ESIS, http://
ecb.jrc.it /esis), which offers for the first time a single
search tool on chemicals and the legislation under
which they are presently covered.
The proposed REACH system foresees the application of
alternative methods to the testing of chemicals pro-
duced or imported in quantities above 1 ton. To achieve
this objective the Commission promotes the use of non-
animal testing methods, such as: (1) refined exposure
information, (2) computer models and (3) cell culture
tests. These new risk assessment strategies are essen-
tial for the implementation of REACH and bear the po-
tential to significantly reduce the costs associated with
it. Responding to these needs, the IHCP has — in addi-
tion to its ongoing activities on cell culture testing and
exposure assessment — launched an initiative on com-
puter models, such as Quantitative Structure-Activity
Relationships (Q)SARS, to promote their development,
validation and implementation for regulatory use. This
involves the work of both the European Chemicals Bu-
reau (ECB) and the European Centre for the Validation
of Alternative Methods (ECVAM).
ECVAM was established by a Communication of the Euro-
pean Commission and Parliament (SEC/91/1794) to sup-
port the implementation of the Directive on animal pro-
tection (86/609/EEC). ECVAM is the European reference
centre for the independent evaluation of the relevance
and reliability of tests for specific purposes (e.g. toxi-
cology assessments of various types of chemicals, qua-
lity control and safety assessments of biologicals),
through research on advanced methods, new test devel-
opment and validation, and the operation of specialised
databases. 11 key-areas have been established or were
reinforced with the support of various working groups
with participation of stakeholders and international ex-
perts. The activity on the validation of computer models
for toxicity assessment, in particular Quantitative Struc-
ture Activity Relationships (QSARS), will be enlarged
over the coming years to respond to the needs regarding
the implementation of REACH. The QSAR Action on the
promotion of the development, validation and imple-
mentation of (Q)SARs is carried out in close collabora-
tion with the European Chemicals Bureau (ECB).
The IHCP Physical and Chemical Exposure Unit (PCE)
was transferred from IES in 2000 and has close links
with industry to work together towards eliminating ex-
isting deficiencies in data on human exposure to chem-
icals. This also allows the JRC to evaluate more accu-
rately the overall risk for European citizens when
exposed to chemicals from various sources (ingestion,
inhalation, skin contact). It provides scientific under-
standing, information and assessment tools to support
the Commission services in evaluating and quantifying
human exposure and risk assessments for environmen-
tal stressors. Stressors include chemicals, UV-radiation,
electromagnetic fields and noise. The overall objective
for the PCE Unit is to develop infrastructure, tools and
reference data to enable harmonised exposure assess-
ment procedures in the EU, and to support the imple-
mentation of key policies and directives, such as the
New Chemicals Policy, the General Product Safety and
Indoor exposure limits for priority pollutants (INDEX).
The European Union has put in place a set of strict pro-
cedures for approving the growth, import and/or use of
GMO food or ingredients. EU legislation guarantees the
consumer’s right to information. Since 1997 labelling
to indicate the presence of GMOs as such or in a product
is mandatory. However, Regulation (EC) 1830/2003 re-
inforces the current labelling rules extending mandato-
ry labelling to all food and feed products. In this con-
text traceability provides the ability to trace GMOs and
products produced from GMOs at all stages of their plac-
ing on the market through the food production and dis-
tribution chains. The Biotechnology and GMOs Unit is
the JRC reference for the provision of scientific and
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Executive Summary
technical support to the EC biotechnology regulatory
framework and for the development of biotechnology
expertise in areas relevant to health and consumer pro-
tection. The Unit work focuses on the development and
validation of appropriate methods for sampling, detec-
tion, identification and quantification of Genetically
Modified Organisms (GMOs) in different types of matri-
ces. In the context of Regulation (EC 1829/2003) on
genetically modified food and feed, the Joint Research
Centre (JRC) of the European Commission and – in par-
ticular - the IHCP Biotechnology and GMOs Unit, was
appointed as the “Community Reference Laboratory”
(CRL). The CRL is assisted in this important task by the
European Network of GMO Laboratories (ENGL), coordi-
nated and chaired by the Unit itself, and considered as
one of the major achievements of the JRC in recent
years. The ENGL constitutes a unique platform for ex-
perts from EU Member States to discuss technical issues
related to sampling, detection, identification and
quantification of GMOs. In support of the Commission
policy, the Unit provides specific technical advice and
expertise to various Commission Services, such as:
the reception of all summary notifications of delibe-
rate field trials (SNIFs), notified under Directive
2001/18/EC and the participation as nominated expert
in the development of an operational Biosafety Clearing
House.
In the last five years, the BMS-Unit has developed as a
horizontal “enabling” technology provider in support of
the JRC priority areas for policy related research. The
Unit’s strength lies in the cross-functional research ac-
tivities, which are performed in the frame of two insti-
tutional Actions on ‘Nanobiotechnology for Health Ap-
plications’ (NBT) and ‘Medical Devices and Health
Technology’ (MEDTECH), which were initiated in the
Sixth Framework Programme. The Nanobiotech project
opens a complete new research field at the IHCP and
JRC, through the development of specific interfaces be-
tween biological/non biological systems. First applica-
tions are linked to controlled surface structures open-
ing route to high selectivity/highly paralleled analysis
systems. The scientific activities in the Action MEDTECH
were concentrated on production technologies for med-
ical radioisotopes and materials research. Special em-
phasis was given to training activities of young re-
searchers including external funding through the Marie-
Curie Programme (Joint ECVAM-BMS MC-Training Site,
individual MC fellowships).
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8The IHCP was established in October 1998 through the
reorganization of existing expertise and structures
within the JRC Institutes in the area of health and con-
sumer protection. Since then the main themes of the
IHCP have been food, chemicals and health carried out
by five scientific Units. In 2002 a reprioritisation exer-
cise was carried out resulting in the integration of the
activities on food products into the Institute for Refer-
ence Materials and Measurements (IRMM) in Geel, Bel-
gium, and the termination of the Unit Support to Phar-
maceutical Regulation (SPR). In the same year, two new
Units were created: “Biotechnology and GMOs” and
“Physical and Chemical Exposure (PCE)”. Into the latter
selected activities from the Institute for Environment
and Sustainability (IES) were integrated.
In the following the main achievements of the different
scientific Units of the IHCP are summarised.
Food Products and Consumer Goods
(part of the IHCP from 1998 to 2002)
The objective of the Food Products and Consumer Goods
Unit was to develop, harmonize and validate analytical
methods in the areas of food safety, food quality and
safety of consumer goods. As a result of a reprioritisa-
tion exercise in 2002, this Unit was integrated into the
Institute for Reference Materials and Measurements
(IRMM) in Geel, Belgium. In 1999 a large part of its
work was dedicated to the support to the Belgian Au-
thorities by developing simplified methods for the de-
termination of polychlorinated biphenyls (PCBs), which
were the source of dioxin contamination detected in
Belgian food and feeds at that time. The emergence of
a new variant of Creutzfeld-Jacob disease during the
BSE (Bovine spongiforme encephalopathy) epidemic
and the subsequent ban on the use of specified risk ma-
terials (SRM), led to an activity, in which a method for
the detection of central nervous tissue (the main SRM)
in meat and bone meal products was developed.
The work in the area of food contact materials focused
on the development and validation of methods for the
determination and detection of Bisphenol-A-Diglycidy-
lether (BADGE) in certain food products (e.g. canned
food), which are able to migrate into food or can react
with other compounds in the food or in the food pack-
age. A web site containing a list of substances used
in materials and articles in contact with food was
launched in 1999 (http://cpf.jrc.it). Research was also
carried out on the migration of Phthalates, which are
used as softeners in PVC toys and children’s articles. In
2003 DG SANCO proposed to designate the food contact
laboratories as a future Community Reference Laborato-
ry (CRL). The use of these substances in toys has been
temporarily banned in 1999 (Commission decision 1999
/815/EEC). The activities on food contact materials
were integrated into the Unit “Physical and Chemical
Exposure (PCE)”.
Physical and Chemical Exposure, PCE
(created in 2002)
In the frame of activities to evaluate human exposure
to environmental tobacco smoke (ETS) components in
indoor environments, a series of tests were undertaken
in 2003 to investigate the impact of various ventilation
rates on the air concentration of ETS-components. The
tests were carried out at the European Commission-
Joint Research Centre’s INDOORTRON facility, a 30 m3
walk-in type environmental chamber.
Preliminary evidence indicates that changes in ventila-
tion rates simulating conditions expected in many resi-
dential and commercial environments during smoking
do not have a significant influence on the air concen-
tration levels of ETS constituents, e.g. CO, NOx, aromat-
ic compounds, nicotine. This suggests that efforts to
reduce ETS originated indoor air pollution through
higher ventilation rates in buildings, including residen-
tial areas and hospitality venues, would not lead to a
meaningful improvement of indoor air quality. Moreo-
ver, the results show that “wind tunnel”-like rates or
other high rates of dilution ventilation would be ex-
pected to be required to achieve pollutant levels close
to ambient air limit values.
The work undertaken at the European Office of Wine, Al-
cohol and Spirit Drinks (BEVABS) ensures effective con-
trol of major fraud, such as sugaring and watering in
the wine sector. Since 2002 BEVABS forms part of the
PCE Unit of the IHCP. One of its core tasks is the man-
agement of a database, which contains information on
thousands of authentic wines produced in the EU since
1991. This includes results of isotopic analysis, as well
as more than 80 additional parameters such as geo-
graphical origin, grape type and chemical analysis.
In early 2004, the PCE Unit expects to pass the SINAL
audit for the extension and accreditation for the meth-
od performed in BEVABS on the analysis of wine, fer-
mented juices, spirit drinks and alcohol and the CERMET
audit for the measurements of chemicals emissions
from products and articles including human exposure to
indoor and occupational environments.
IHCP Scientific Highlights 1998-2003
9Biotechnology and Genetically Modified Organisms,
B&GMOs (created in 2002)
The increasing public debate on genetically modified
organisms (GMOs) and their effect on human health and
the environment as well as the moratorium for EU ap-
proval in 1999 made the activities on GMOs a priority
area of the JRC and the IHCP. In 2002 these activities
were concentrated in a new Unit of the IHCP “Biotech-
nology and GMOs” with the objective to provide scien-
tific and technical support for the implementation of
EU policy in the area of biotechnology. A major task in
1999 was the establishment of a system for the ex-
change and analysis of the information within notifica-
tion files for R&D field trials before being distributed to
the Member States’ Authorities for approval. Submis-
sion of notification dossiers is made using the Com-
mission’s Summary Notification Information Format
(SNIF). During 2003, the system allowed the circulation
of 82 SNIFs regarding deliberate field trials, and 23
SNIFs regarding placing on the market. In the area of
detection of GMOs the IHCP was involved in a validation
study of GMO material in flour raw materials derived
from modified crops (Roundup-Ready®‚ soybeans and
BT-176 maize). The results showed that the PCR (poly-
merase chain reaction) based method is a suitable
screening technique for these specific flours present in
various concentrations in their non-GMO counterparts.
In order to facilitate and speed up the collection and
exchange of information, a “European Network on GMO
Laboratories (ENGL)” coordinated by the IHCP was
founded in June 2000 upon request from Member
States. Four training courses on the analysis of food
samples for the presence of Genetically Modified Organ-
isms were held at the IHCP in 2000 in collaboration
with the World Health Organization (WHO).
In the context of the European Union GM Food and Feed
Legislation a “Community Reference Laboratory (CRL)”
has been established at the IHCP. The core task of the
CRL is the technical evaluation and validation of quan-
titative detection methods for GM Food and Feed as
part of a Commission authorisation procedure. The
Joint Research Centre (JRC) of the European Commis-
sion, and — more precisely — the Biotechnology and
GMOs Unit, has been given the mandate for the opera-
tion of the CRL. It does so in collaboration with a
European Network of more than seventy National Con-
trol Laboratories, assembled in the European Network
of GMO Laboratories (ENGL).
European Chemicals Bureau, ECB
The ECB carries out technical and scientific work need-
ed for the development, introduction and adaptation of
testing methods of Annex V to Directive 67/548/EEC. It
plays a central role in the establishment of the New EU
Chemicals policy (Registration, Evaluation and Authori-
zation of Chemicals, REACH), which the Commission
proposed on 29 October 2003 (COM(2003) 644 final). A
report “Assessment of Additional testing Needs under
REACH” (EUR Report 20863 EN, 2003) was produced by
the IHCP concluding that considerable saving can be
made on the direct testing costs for chemicals safe-
ty assessment if (Q)SARS — (Quantitative) Structure
Activity Relationships —, are applied. The IHCP has
launched an initiative on estimation techniques that
are useful for regulatory purposes, such as (Q)SARS, to
promote their development, validation and implemen-
tation for regulatory use. This involves the work of both
the European Chemicals Bureau (ECB) and the European
Centre for the Validation of Alternative Methods (EC-
VAM). In relation to the implementation of REACH, the
JRC anticipates that a certain number of validated
(Q)SARs will have to be available by 2006. The (Q)SARS
activity was integrated into ECVAM in 2003.
During the last five years the ECB increased its large
network of collaborating partners in industry and aca-
demia in the member states, and on its track record in
successfully training experts on risk assessment tools
(the European Union System for Evaluation of Sub-
stances, EUSES) and the International Uniform Chemi-
cal Information Database IUCLID. In 2003 the ECB es-
tablished the European Chemical Substances Informa-
tion System (ESIS, http://ecb.jrc.it/esis), which — for
the first time — offers a single search tool on chemi-
cals and the legislation under which they are presently
covered.
The European Centre for the Validation
of Alternative Methods, ECVAM
Together with the ECB, ECVAM plays a key role in the
implementation of REACH aiming to minimise the use
of experimental animals and to speed up the policy im-
plementation through the development and validation
of more cost-effective and faster in vitro techniques.
In support to the implementation of the 7th amendment
of the cosmetics Directive (Council Directive 2003/15/
EC), which foresees phasing out animal experiments
within 10 years, ECVAM co-ordinated the creation and
operation of several international ad-hoc working
groups to establish the “state-of-the-art” of alternative
methods for human health effects, in support to a
jointly established working group of Commission servic-
es and stakeholders.
ECVAM conducts research in several areas of toxicology
relevant to the safety testing of chemicals of various
kinds (including cosmetics and pharmaceuticals). Par-
ticular emphasis was given on the establishment of the
human embryonic stem cell technology. It has been set
up a consortium of about 30 partners to develop in vitro
tests that can be used as building blocks in future test-
10
ing strategies with the aim to detect reproductive toxi-
cants. The Integrated Project proposal (ReProTect) has
been successfully submitted to DG RTD and it’s foreseen
to start on the 1st of July 2004. A second Integrated
Project, A-Cute-Tox, aiming at developing a replace-
ment strategy for acute toxicity, was selected and is be-
ing currently negotiated.
In 2003 the validation study on pyrogenicity testing,
guided by ECVAM, was successfully completed. It
showed that a few human blood cells are able to elimi-
nate animal testing for parenteral (non-oral) drugs,
saving the lives of 200.000 laboratory rabbits per year
in Europe.
The JRC hosted the 1st Meeting of the OECD Expert
Group on (Q)SARs to develop a proposal for the QSAR
activity, which was subsequently adopted by the OECD
Joint Meeting of the Chemicals Committee and Working
Party on Chemicals, Pesticides and Biotechnology.
ECVAM’s Scientific Information Service (SIS) has been
extended to an interactive information service, reach-
ing 2900 registered and active users from 65 countries.
Biomedical Materials and Systems, BMS
In the last five years, the BMS Unit has developed as a
horizontal “enabling” technology provider in support of
the JRC priority areas for policy related research. The
Unit’s strength lies in the cross-functional research ac-
tivities, which are performed in the frame of two insti-
tutional Actions on ‘Nanobiotechnology for Health Ap-
plications’ (NBT) and ‘Medical Devices and Health
Technology’ (MEDTECH), which were initiated in FP6.
The activities in NBT regarding the development of new
biosensors and advanced methods for the detection of
toxicological endpoints are centred in one of the most
promising and rapidly expanding fields of current re-
search being highly relevant for the scientific-techno-
logical underpinning of toxicity testing required by the
REACH legislation and in the emerging priority area of
Environment and Health. The competencies in these ar-
eas were developed from long standing experience in
plasma surface processing and surface characterisation.
Prenormative research in support to the Nickel Directive
94/97 was carried out with the definition and publica-
tion of selected test methods, which were adopted by
the European Committee for Standardisation (CEN). An
orthopaedic implant testing laboratory was set up with
a range of wear testing facilities (screening devices and
hip/knee joint simulators) to improve and harmonize
wear test methods for hip and knee prostheses in sup-
port to Directive 93/44/EEC including methods for the
characterization of ceramic and polyethylene wear de-
bris.
The MEDTECH Action covers the cyclotron activities and
deals with radioisotope production for research use. The
focus lies on new production technologies of novel bio-
medical radioisotopes for diagnostic and therapeutic
applications.
BMS Unit, together with ECVAM, is selected as a Marie
Curie Training Site for biomaterials testing using radi-
otracers. In the area of optical imaging, an endoscopic
fluorescence based method for tissue characterization
was developed, for which a US patent is pending.
HUMAN RESOURCES
This section gives an overview of the staff situation in
2003 and a historic overview of the staff situation over
the last five years, distinguished into statutory and col-
laborative staff (trainees, PhD and Post Doc grant hold-
ers, visiting scientists, national experts).
Statutory staff distribution–2003
Out of the total JRC staff, IHCP employs 203 statutory
staff (including officials, temporary agents and auxilia-
ry agents), and without auxiliary agents a total of 141
staff members:
The IHCP statutory staff (without auxiliary agents) con-
sists of 64 (45%) scientific staff, 55 (39%) technical
staff, and 22 (16%) staff providing management sup-
port. The IHCP scientific staff counts on significant ex-
pertise in a wide range of disciplines, such as Analytical
Chemistry, Biology, Biometrics, Biophysics, Engineer-
ing, Food chemistry, Information technology, Science,
Medicine, Pharmacology, Physics, Radiochemistry and
Toxicology.
Collaborative Staff with Member States
and Third Countries
The IHCP hosts a large number of collaborative staff
(trainees, grant-holders, visiting scientists, seconded
national experts) in order to adjust to its research ac-
tivities.  More specifically, the IHCP hosted 41 collabo-
rative staff in 2003:
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Management
Support
IHCP Statutory Staff (December 2003) M F Total
Officials 60 35 95
Temporary Agents on 5-year renewable contracts 26 19 45
Temporary Agents on 3-year non-renewable contracts 1 0 1
Total IHCP (without auxiliary agents) 87 54 141
Auxiliary Agents on 1-year non-renewable contracts 26 36 62
Total IHCP (with auxiliary agents) 113 90 203
IHCP Collaborative Staff (December 2003) M F Total
Trainees 5 3 8
Post-Graduate grant-holders 8 11 19
Post-Doc grant-holders 5 4 9
Visiting scientists 3 1 4
Seconded National experts 1 0 1
Total 22 19 41
The IHCP in Figures–2003
39%
Technical
staff
16%
IHCP Statutory staff
(without auxiliary agents)–2003
45%
Scientific
staff
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BUDGET
This section summarizes the financial resources of the
IHCP in 2003 and gives a historic overview over the last
5 years. The EU Framework Programmes (FP) for Re-
search and Development set out the general research
priorities of the European Union in accordance with Ar-
ticle 169 of the EU Treaty.  A total budget of 17.600 M€
was allocated to the Six Framework Programme – FP6
(2003-2007). The JRC (Institutes) received an amount
of 1.154 M€ (6.5%) out of the total FP6 budget. The
IHCP has been attributed an amount of around 39 M€
for the year 2003.
In general, IHCP credits come from the institutional
budget (made available directly from the aforemen-
tioned European budget to the JRC), competitive activ-
ities and associated states.
Institutional activities
The JRC defines its broad research areas into its multi-
annual JRC Work Programme. The JRC Work Programme
is updated annually (annual Work Programmes), and
where appropriate, adaptations are made following ex-
changes with “customer” Directorate Generals to review
progress and consider new needs.  The 2003 JRC Work
Programme is arranged according to the following pro-
gramme lines: a) safety of food and chemicals, b) envi-
ronment, c) dependability of Information Systems and
Services, and d) nuclear safety and safeguards.
The majority of the IHCP projects contribute to the ‘Safety
of food and chemicals’ programme line. The available cred-
its to IHCP are divided into staff expenses, means of exe-
cution (maintenance of buildings and equipment, electric-
ity, insurance, consumables, etc.) and operational credits
(scientific acquisitions). The following table pre-sents the
IHCP institutional budget based on its projects in 2003:
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IHCP Institutional Budget 2003–Institutional Projects (K€)
UNIT ACTIVITIES
Staff Means of Specific
Total
costs execution credits
ECVAM Development, validation and promotion of advanced non- 6,116 170 2512 8,798
animal test methods for chemical substances and products
ECB 8,898 80 788 9,766
ECB Assessment of Chemicals 8,251  675 8,926
QSAR’s Development, validation and dissemination of quantitative 329  75 404
structure-activity relationships (QSARs)
RASEP Risk assessment in support of EU policies (RASEP): 398  38 436
Methodology and refinement
BMS  7,129 80 525 7,734
Medtech Medical devices and health technology (MEDTECH) 4,264  325 4,589
Nanotech Nano biotechnologies for health application (Nano Biotech) 2,945  200 3,145
PCE  5,816  130 850 6,796
Thexas- Total Human Exposure Assessment Study including toxico- 3,469  325 3,794
Chem genomic approach (THEXAS-chem)
Thexas- Total Human Exposure Assessment Study (THEXAS-phys) 1,363  125 1,488
Phys
BEVABS European Office for Wine, Alcohol and Spirit Drinks (BEVABS) 1,114  400 1,514
GMO S/T support for the implementation of GMO legislation 4,316 230 1,375 5,921
Totals  32,275 690 6,050 39,015
Competitive activities
The advantages of participating in competitive activi-
ties are that IHCP gains access to new expertise, and
shares its own competencies and facilities. Competitive
activities also provide another source of income besides
the institutional budget. In accordance with the JRC’s
own regulations, competitive projects must comple-
ment the JRC’s mission and must respect the subsidiari-
ty principle.
There are three types of competitive activities:
• Participation in shared-cost activities (SCA) with oth-
er successful consortia
• Activities financed in the context of other EU poli-
cies (non-research) upon request of other Commis-
sion services (OCA)
• Work undertaken for third parties on a contractual
basis (TPW)
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Income from Competitive Activities - 2003 (K€)
Type K€ %
Shared Cost Actions (SCA) 472.894 5
Other Competitive Activities (OCA) 6.523.843 70
Third Party Work (TPW) 2.382.082 25
Total 9.378.819 100
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Budget History
1. B. De Bernardi served as Unit Head of the Management Support Unit (MSU)
until 31st October 2003. Following his retirement, R. Crandon was appointed
as Head of Unit of the MSU on 1st January 2004.
2. The Biotechnology and Genetically Modified Organisms (B&GMO) Unit was
officially established in November 2002 located in Ispra. G. Van den Eede
was appointed as the first Head of Unit on 1st April 2003.
14
IHCP Organisational Chart
Director
K. van Leeuwen
Management
Support1
R. Crandon
Physical and
Chemical Exposure
D. Kotzias
European Centre
for the Validation of
Alternative Methods
T. Hartung
European
Chemicals
Bureau
G. Vollmer
Biomedical
Materials and
Systems
H. Stamm
Biotechnology
and GMOs2
G. Van den Eede
Institutional Project
Support to the Implementation
of the Community Policy on biotechnology and GMOs
Some Shared Cost Actions
GM-FOOD & FEED
Biotechnology and GMOs
Web information resources
http://biotech.jrc.it/
http://engl.jrc.it
http://gmoinfo.jrc.it
http://gmotraining.jrc.it
http://ihcp.jrc.cec.eu.int
m&
bg os
The IHCP Biotechnology and GMOs Unit (B&GMOs) was
created on November 1st 2002. The foundation of this
Unit reflects the importance of biotechnology and
GMOs for the EU policy and the large amount of requests
for technical support made to the JRC. The work of the
Unit focuses on the development and validation of ap-
propriate methods for detection, identification and
quantification of GMOs in different types of matrices.
The Unit operates the European Network of GMO Labo-
ratories (ENGL), which is seen worldwide as a network
of scientific reference. The Unit has expertise in envi-
ronmental risk assessment, in bioinformatics and in
issues related to sampling. The Unit works closely with
the JRC Institute for Reference Materials and Measure-
ments (IRMM), which is responsible for the production
of GMO Certified Reference Materials, and with the JRC
Institute for Prospective Technological Studies (IPTS)
on the elaboration of topical forward studies.
The IHCP - Biotechnology and GMOs Unit is the JRC re-
ference for the provision of scientific and technical sup-
port to the EC biotechnology regulatory framework and
for the development of biotechnology expertises in areas
relevant to health and consumer protection. The Unit
work focuses on the development and validation of ap-
propriate methods for sampling, detection, identification
and quantification of Genetically Modified Organisms
(GMOs) in different types of matrices. In the context of
Regulation (EC) 1829/2003 on genetically modified food
and feed, the Joint Research Centre (JRC) of the Europe-
an Commission and — in particular — the  IHCP Biotech-
nology and GMOs Unit, was appointed as the “Community
Reference Laboratory” (CRL). The core task of the CRL is
the technical evaluation and validation of detection
methods for GM food and feed as fundamental part of the
Commission authorisation procedure for GMOs.
The CRL is assisted in this important task by the Europe-
an Network of GMO Laboratories (ENGL), coordinated and
chaired by the Unit itself, and considered as one of the
major achievements of the JRC in recent years. The ENGL
constitutes a unique platform for experts from EU Mem-
ber States to discuss technical issues related to sam-
pling, detection, identification and quantification of
GMOs.
In support of the Commission policy, the Unit provides
specific technical advice and expertise to various Com-
mission Services, such as: the reception of all summary
notifications of deliberate field trials (SNIFs), notified
under Directive 2001/18/EC, the participation as nomi-
nated expert in the development of an operational Bi-
osafety Clearing House and the support to the EU serv-
ices in the WTO dispute launched by the USA, Canada
and Argentina.
The Unit, also in support to ENGL, is actively involved
in research projects in the fields of molecular biology,
method development and sampling for GMO detection
and quantitation. A great deal of attention is also given
to bioinformatics, to the maintenance and updating of
a database of analytical methods for DNA and protein
detection and quantification, and to the development
of a molecular register containing DNA sequences of all
authorised GMOs.
Over the years, the Unit has developed an ad hoc know-
ledge of the different aspects related to GMO analysis
and it has devoted significant effort in transferring this
expertise to control laboratories within and beyond ac-
tual EU borders. Excellent contacts and collaboration
have been established and are continuously strength-
ened with international research organisations, stand-
ardisation bodies (i.e. CEN), as well as with the bio-
technology industry.
Further information on the work and activities of the
ENGL, including guidance documents and associated in-
formation, can be found at: http://engl.jrc.it
THE EUROPEAN NETWORK
OF GMO LABORATORIES (ENGL)
The European Network of GMO Laboratories (ENGL) is set
up to contribute more effectively to the European harmo-
nisation and standardisation of means and methods for
sampling, detection, identification and quantification of
Genetically Modified Organisms or derived products in a
wide variety of matrices, covering seed, grains, food, feed
and environmental samples. As such, it is aimed to act as
a scientific and technical European Union network of ex-
cellence within the context of EU GMO regulation. Pro-
jects of excellence and innovation and rapid exchange of
data within its members is key to ENGL.
The scope is to create a unique platform for experts
that are involved in the sampling, detection, identifica-
tion and quantification of GMOs — being in the envi-
ronment, food, feed and seeds — and where technical
items can be put forward and discussed, namely:
• Method development for qualitative and quantitative
analysis;
• Molecular biology technology transfer;
• Validation and proficiency studies of methods suita-
ble either for screening of various matrices for the
presence of GMOs, or for the estimation of the GMO
quantities present;
• Reference material (the responsibility for this work
package lies with the JRC’s Institute for Reference
Materials and Measurements);
16
Biotechnology and GMOs (B&GMOs)
• Sampling strategies and procedures for different GM-
commodities (seeds, grains, raw material, products
for final consumer or mass caterers);
• Databases and bioinformatics and requirements for
unique identification of GMOs and setting up of data-
bases that contain these molecular data;
• Training has been organized at the Ispra site.
Members of this Network, inaugurated in Brussels in
December 2002 in the presence of Research Commis-
sioner Ph. Busquin and of the Director General of the
JRC, Mr B. Mc Sweeney, met in 2003 several times for
plenary sessions, for steering committee meetings
and ad hoc working group meetings addressing speci-
fic relevant topics. The 2nd official plenary session has
been held in April and the 3rd plenary session in No-
vember.
ENGL invited EU member states and future AC member
states to all the working group sessions and its role is
also to support and facilitate the interaction with all
global trade partners. During all plenary meeting a
number of experts from Accession Countries were invit-
ed to be present as observer. In 2004 ten New Member
States will join the Network as official members nomi-
nated by Competent Authorities of their own countries.
By mid-2004, over 70 laboratories will have an official
membership to ENGL.
VALIDATION OF METHODS FOR GMO DETECTION
Method validation for GM detection is an area where
the JRC is actively involved and this commitment has
grown considerably since 2002. In particular, the Regu-
lation (EC) 1829/2003 of the European Parliament and
of the Council of 22 September 2003 on genetically
modified food and feed establishes the Community Ref-
erence Laboratory (CRL) and the Annex of the Regula-
tion lays down the duties and tasks of the CRL. The CRL
is the Joint Research Centre, assisted by the ENGL in its
main task: the validation of methods with respect to
the GM Food and Feed Regulation. The Regulation en-
tered into force on April 18th, 2004.
For its preparation, the Unit led in 2003 an ENGL Work-
ing Group on Validation. As a result, a document “Defi-
nition of minimum performance requirements for ana-
lytical methods of GMO testing” was accepted by the
ENGL Plenary Meeting in November 2003. The document
provides information about the criteria and require-
ments for method validation with respect to the regula-
tory compliance and control purposes. The document
was also used as a guideline during the drafting of the
Regulation (EC) 641/2004 in which CRL procedures are
defined and described.
In 2003, method validation was mainly carried out
within the EU shared cost action project QPCRGMO-
FOOD. Altogether, about 25 multi-laboratory valida-
tions with at least three laboratories have been carried
out within the project. Among those, methods satisfy-
ing pre-validation requirements were then selected for
a full ring-trial with more than 10 participating labora-
tories (i.e. extraction methods for maize matrices as
well as Zein, ADH, HMG and Invertase reference gene
systems for maize) — and some of them were later val-
idated in the context of regulatory compliance (event-
specific quantitative PCR methods for Bt11 and T25
maize lines). The project has contributed also to the
development, testing and implementation of the modu-
lar validation approach, in which the extraction meth-
ods, reference gene systems and GMO-specific systems
can in principle be validated separately. Concurrently,
the approach has been adopted by the CEN and is sug-
gested to form the frame for the standardization of GMO
testing methods within Europe. In 2003, the Unit in
collaboration with the ENGL concluded the first valida-
tion process directly related to a GM authorization in
Europe — for the approval for marketing of sweet maize
derived from maize Bt11. The results were presented to
the EC Standing Committee in November 2003. Concur-
rently, several validation studies related to the GM au-
thorizations were launched in anticipation of the CRL
establishment (e.g. for the detection of NK603 and
GA21 maize).
In the context of FP5 (Fifth Research Framework Pro-
gramme), the Unit participated in a number of research
projects, which have been completed successfully (such
as ENTRANSFOOD and QPCRGMOFOOD). A number of new
methods have been developed and validated. The Unit
was also involved in the preparation of new research
project proposals: SIGMEA (Sustainable Introduction of
GMOs into European Agriculture) and Co-extra (GM and
non-GM supply chains: their co-existence and traceabil-
ity). Both proposals were successful: SIGMEA project
officially started in May 2004, and the Co-extra propos-
al is at the contract negotiation stage. In both projects,
the Unit is in charge of coordinating a work-package re-
lated to GM detection and sampling. Several members
of the ENGL also participate in these projects.
Activity of Proficiency Testing (PT)
Proficiency Testing (PT) is a quality tool that measures
the outputs of a laboratory. The Unit is actively in-
volved in PT, which is a requirement for the implemen-
tation of analytical quality systems. The PT schemes to
which the molecular biology laboratory has participat-
ed are:
• GeMMa (Central Science Lab. – York, UK) Food Analy-
sis Performance Assessment Scheme - 9 Rounds
• USDA – Gipsa (Grain Inspection Packers and Stock-
yards Administration) – 3 Rounds
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Several types of samples have been analysed during PT
activity, including meat pâté, soya milk powder, sau-
sage meat, animal feed, cakes and biscuits. Analyses
have been carried out for GMO screening, identification
(qualitative methods) and quantitation. A number of
analytical techniques have been employed, including
PCR, nested PCR, real-time PCR and immunoassay tests
(Lateral Strip Test). Particular focus has been put on
identification and quantitative analysis of mixtures of
GM maize events present in the same sample. The labo-
ratory sensibly extended its capacity to reliably analyse
an increasing number of GM events: routine analyses on
GM maize lines GA21, MON863, NK603, MON810, Star-
link, Bt176, T25 and Bt11 are now carried out. Excel-
lent scores for the results produced have constantly
been received.
Collaboration with IRMM
for the certification of CRMs
In the context of new methods validation, candidate
Certified Reference Materials of maize GA21 and
MON863 were provided to the Unit by JRC-IRMM for pre-
marketing testing. Sample were extracted and tested on
real-time PCR, specifically for intra and inter-bottle ho-
mogeneity, an important parameter assessed before
commercialisation of CRMs. Results were provided to
the IRMM as supporting data for the certification of
these materials.
SAMPLING
During 2003 the Unit continued its activity for the
identification and development of appropriate sampling
strategies to support EU legislation for the detection
and quantification of GMOs in different market prod-
ucts. Progresses were achieved in the four components
structuring the sampling research area: theoretical-
statistical work, software development, KeLDA research
project, and ad-hoc technical advice.
Theoretical-statistical work
Following the publication of a new approach to investi-
gate the effects of different levels of heterogeneity on
the accuracy of different sampling plans for the detec-
tion of GM particles within kernel lots, we have devel-
oped a novel statistical model to assess incremental
sampling efficiency as function of lot heterogeneity. In
particular, the model allows estimating the sampling
error associated to different sampling protocols (in
terms of both number and size of samples taken from
the lot), applicable to any consignment of particulate
material with respect to any kind of contamination, in-
cluding GMOs. The novelty of our approach is the free-
dom from any distribution constraints. This new model
is at the basis of the sampling protocols for grains rec-
ommended in the EU Recommendation “on technical
guidance for sampling and detection of GMOs and mate-
rial produced from GMOs as or in products” in the con-
text of Regulation (EC) 1830/2003.
Software Development
KeSTE (Kernel Sampling Technique Evaluation), a soft-
ware designed to evaluate suitability of sampling strate-
gies to detect impurities of large kernel lots virtually cre-
ated (investigative tool) or actually sampled (data
analysis supportive tool), was distributed at the second
ENGL plenary meeting (April 2003). KeSTE is now availa-
ble on the web, free-of-charge.
During 2003 the B&GMO Unit started to develop a new
software CoDE (Contaminant Distribution Estimate) de-
signed to quantify the sampling error associated to dif-
ferent sampling protocols according to the Unit’s new
distribution-free statistical model. CoDE will be distrib-
uted during 2004. It will serve as a supporting tool for
the implementation of the sampling protocol defined in
the EU Recommendation in the context of Regulation
(EC) 1830/2003.
EU pan-project KeLDA
KeLDA (Kernel Lot Distribution Assessment), initiated in
December 2002, is the first research project investigat-
ing the degree of heterogeneity present in real lots and
providing real data on this issue, worldwide. During 2003
participant laboratories from 10 Member States have
sampled and screened 12 soybean lots (100 samples per
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KeSTE software
CoDE software
lot, which had been homogenized and grinded by JRC-
IRMM), for the presence of GM materials. The B&GMOs
Unit is responsible for the quantitation of all positive
samples and has completed the analysis of five lots dur-
ing 2003. The obtained preliminary results indicate that
GMOs distribution can vary among lots (see figure be-
low) and it cannot be assumed a priori to be random, as
currently done by most internationally adopted sampling
protocols.
Technical advice
In order to support the achievement of sampling har-
monization, the B&GMO Unit has provided technical ad-
vice both internally to DG SANCO and DG ENV for the
definition of sampling protocols in the context of the
new EU GMO-related legislation, and externally to CEN
for the definition of a new CEN-ISO Sampling Standard
(prEN ISO 21568:2003).
MOLECULAR BIOLOGY LABORATORY
The need to comply with mandatory threshold and la-
belling requirements introduced by the new GM food
and feed (1829/2003) and traceability (1830/2003)
Regulations has increased the need for new and reliable
methods for GMO detection in food and feedstuffs. The
B&GMO Unit is the JRC reference for the provision of
scientific and technical support to the EC biotechnolo-
gy regulatory framework and to develop biotechnology
expertise in relevant areas for health and consumer pro-
tection. It has dedicated considerable efforts to the de-
velopment, optimisation and validation of molecular
biology-based methods.
Methods development and optimisation
The research activity of the Unit focused on the follow-
ing projects:
• Development and optimisation of a multiplex real-time
PCR based system for the quantification of the CaMV
35S promoter in GM maize lines. The project started in
the year 2002 and was completed during the first half
of 2003.  The method, developed and optimized on
maize MON810 for a reliable estimation of the GM con-
tent, has been applied for the study of the effect of
target copy number in different GM events on the ac-
curacy of GMO quantitation. The method is currently
used in GMO quantitation in the frame of activities of
Proficiency Testing carried out by the B&GMO Unit.
Following an expression of interest for this method at
European level, the organization of a collaborative tri-
al for its validation during 2004 is foreseen.
• Development and optimization of real-time PCR systems
using novel probe systems (MGB – minor groove bind-
ing). The aim of the project was to assess and compare
the efficiency of the novel probe design with respect to
the traditional Taqman degradation probes. A multiplex
method for the quantitation of the Roundup Ready soy-
bean was developed and characterized. The perform-
ance criteria, studied during the in-house validation of
the method, showed that this system could be success-
fully applied to the quantitation of GM soybean in raw
materials. Moreover, due to the characteristics of stabil-
ity and sensitivity offered by the innovative real-time
chemistry, the method allows for improved quantitation
of GM ingredients in highly processed materials.
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• Reference genes copy number in maize (the pTetra
Project). The relative quantification of a GMO with
the real-time PCR technique is achieved by normalis-
ing the number of genetically modified genomes with
the number of total genomes of the given species, de-
termining the amount of a GMO specific sequence and
of a species-specific endogenous reference gene. The
variability in the copy number of the most used refer-
ence genes causes major problems in the accurate
quantitation of GMOs, leading to significant analyti-
cal errors. With the aim to address this problem and
develop a novel approach that could help improving
the precision of the tests, a plasmid containing the
target sequences of four maize reference genes (Zein,
Invertase, HMG and ADH) was constructed; the refer-
ence genes were inserted in a 1:1:1:1 ratio. The plas-
mid was used as an equimolarity-based reference ma-
terial allowing the direct quantification of the four
reference genes in maize. The studies, conducted on
30 different GM and wild type maize lines, demon-
strated that different endogenous genes present a
certain degree of variability across the species, and
this variability has a negative impact on the accuracy
of GMO quantitation. The most stable endogenous
gene was identified and its use in GMO testing imple-
mented and recommended.
• Plasmid-based reference materials for the quantifica-
tion of GMOs. Plasmids are a promising alternative to
the matrix matched certified reference materials com-
monly used in GMO detection, due to their ease of
production, low cost and flexible possibility of use.
The project led to the production of tandem-marker
plasmids containing simultaneously specific target
sequences for the GMO of interest and a species-spe-
cific reference marker sequence in a 1:1 ratio. These
plasmids have been tested and calibrated as real-time
PCR standards for the use in GMO quantitation. As
well as serving as reliable standard materials, the
plasmids developed represent a powerful molecular
tool in determining the precise relative dosages of
the transgenic sequences with respect to endogenous
species-specific markers in transgenic maize lines.
Genomics
According to Regulation (EC) 1829/2003 on Genetically
Modified Food and Feed, an application for authoriza-
tion of GM food needs to be accompanied by a method
of detection and identification of the transformation
event. Detection methods for GM constructs are mostly
based on GM specific DNA sequences and, often, also on
plant specific DNA sequences that flank the inserted
transgene (event specific detection method). These de-
tection methods rely on the assumption that the GM in-
serts remain stable in the genome. However, little is
known about the fate of a GM construct, once it is in-
troduced in the plant genome. What is the effect of
conventional agricultural breeding or what might be
the influence of environmental conditions and stresses
on the integrity and the position of the insert, the
flanking plant regions?
Stability of transgenic constructs is being studied in
our Unit, in an ongoing collaboration with the CLO in
Belgium. Part of the project consists of a detailed char-
acterization of several GM constructs, integrated in the
plant.  Another part involves a study of the stability of
the TDNA transgene in several lines of the model plant
Arabidopsis thaliana. Since several thousands of plants
will be screened, a significant effort was invested in the
year 2003 in developing analysis techniques that are
fast, reliable and repeatable: quick plant DNA extrac-
tions and a semi high-throughput analysis system, us-
ing fluorescent labelling of the DNA fragments com-
bined with an analysis via capillary gel-electrophoresis.
The technique of Single Site Conformational Patterns
(SSCP) was established with a variety of plant-derived
DNA fragments. This allowed the detection of re-
arrangements that affect the conformation of a DNA
fragment: single nucleotide differences (SNP: single nu-
cleotide polymorphisms), deletions and insertions.
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Minor Groove Binding (MGB) probes provide higher specificity
and stability in GMO quantitative analysis
Taq polimerase
Single Site Conformational Pattern of 2 DNA fragments
with 1 nucleotide change: C to G.
Proteomics
During 2003, a new approach for the detection and
quantification of GMO specific proteins in raw materi-
als, based on Luminex technology, was developed. The
methodology allows the quantitation of MON810 and
Bt11 specific proteins in maize flour samples. The assay
has been proven to be applicable over a broad range of
GM contamination levels (0.1% to 100%).
In addition, the optimization of a multiplex protein as-
say was initiated in 2003 and it is on going. In order to
overcome the lack of commercially available antibodies,
a specific set of selected proteins (CRY1AB and EPSPS)
were successfully expressed in vitro. These proteins
were used as calibrants for the system and will be used
for the production of the corresponding antibodies.
Although protein-based methods are not at present
widely applied in Europe, they can find practical appli-
cations as cost and time efficient tools for GMO screen-
ing and for multi-events analyses. In order to verify if
ELISA-based methods can be a valuable alternative to
DNA-based methods for GMO surveys, our Unit is com-
paring the performance of some of the most commonly
used ELISA kits.
Training
The activity started in the year 2000 as part of the col-
laboration between JRC and WHO to promote food safe-
ty related issues in WHO European Region, inside and
beyond current EU borders, with special consideration
for Accession Countries, as well as Central and Eastern
Countries with transitional economies. The experience
was very positive followed by intense contacts with the
participants, who frequently requested our advice for
the implementation and/or optimisation of laboratories
devoted to the analyses for GMO detection. A second
series of three Training Courses was organized in the
years 2002-2003, with extensive participation of candi-
dates from Accession Countries.
To enlarge and enhance the benefits of training and to
support local training initiatives, the B&GMO Unit ex-
plored the possibility to act as a Training Centre for
trainees. For this purpose, one scientist from the Agri-
cultural Biotechnology Centre (Environmental Biosafety
Research Institute - Gödöllõ, Hungary) was hosted for 2
months in the B&GMO facilities. As a successful follow
up of this initiative a Training Course, specifically di-
rected to Accession Counties, took place in Gödöllõ, in
November 2003.
Additionally, a training manual as a permanent source
of information describing all the techniques currently
used for the detection and quantification of GMOs was
produced, edited and published in 2003 (http://
gmotraining.jrc.it/). The manual covers a wide variety
of techniques for GMO detection, identification, charac-
terisation, and quantification, including theoretical in-
formation crucial for anyone wishing to enter the field
of GMO detection. The manual, which is the first one
published on this topic, is currently being translated
into Turkish and Russian for further publication.
E-training tools within the JRC Enlargement action
In order to reinforce the Enlargement Action and respond
to the continuously increasing need of training beyond
the available training capacity, a new strategy based on
the use of multimedia tools for training was proposed
and introduced. The aim is to increase efficiency, produc-
tivity and availability of training efforts by complement-
ing traditional training courses with new tools, such as
interactive DVD training. Among other topics, GMO was
selected as the topic for the first pilot e-training project
to be developed. During 2003 large effort was devoted to
the production of this multimedia interactive didacti-
cal product. Theoretical lessons and seminars (as slide
shows with verbal explanation), illustrations of practical
laboratory work (videos explaining each step of the pro-
cedures), and relevant documents (manual, glossary and
web links) will provide all information needed for the
21
Quantification of MON810 and Bt11 GMO proteins in maize
flour samples using Luminex MAP technology.
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analysis of GMOs, in multimedia interactive format re-
sembling a traditional training course. This activity is
still ongoing and the release is expected in 2004.
Finally, during 2003 three DNE/VS from Romania, Czech
Republic, and Poland were hosted and trained for a to-
tal period of 10 months. During this period, specific in-
dividual work programmes were followed to respond to
individual specific needs in the field of GMO detection,
and to allow direct participation in ongoing research
activities.
BIOINFORMATICS AND ANALYTICAL
METHODS DATABASES
During 2003, efforts on building a bioinformatics ex-
pertise were focused mainly on pursuing the develop-
ment of the ENGL Molecular Register and the GMOs
methods database. In response to the request of the al-
lergen expert community addition the Unit has as-
sessed the current state of the art of publicly available
allergen databases and associated bioinformatic tools.
ENGL Molecular Register
The Unit, with the input of competent authorities, bioin-
formatics experts and computer scientists, compiled the
ENGL Molecular Register. This Register provides access to
a GMO events database and to relevant analysis tools. The
Molecular Register contains all available sequencing in-
formation and reference material for GMOs authorised to
circulate within the Community. It also contains, where
available, relevant information concerning GMOs that are
not authorised in the European Union. The development
of the Molecular Register is now completed and the pro-
totype is currently being tested before final release.
Reference Allergen Register
One of the main conclusions of an ad hoc meeting on
Allergen Database was the need to identify the current
state of the art of publicly available databases and as-
sociated bioinformatics tools.
As a complement to the activity on the Reference Aller-
gen Register itself, the Unit is participating to the IN-
FORMALL concerted action project. The 3 years project,
which started in 2003, aims at developing communica-
tion strategies in the food allergy area and promoting
the provision of visible, credible sources of information
appropriate for different stakeholders including con-
sumers, industry and regulators.
GMO methods database
The new Regulation (EC) 1830/2003 on traceability and
labelling requires the adoption of appropriate and cost-
effective control and inspection measures for the analy-
sis of GMOs in the food chain. Access to reliable infor-
mation on methods for the detection, identification,
and quantification of GMOs is then fundamental for le-
gislative enforcement. The Unit developed a data-
base (http://biotech.jrc.it/) to allow direct and user-
friendly access to information regarding methods for
GMO analysis. The database is organized in three sec-
tions: 1) general information on the GMO and the corre-
sponding method; 2) technical information on the me-
thod; 3) specific information on the proficiency of the
method and its validation status, if available. During
2003, the structure, data content and layout of all three
sections were improved: in order to facilitate the selec-
tion of the appropriate method, 105 new fields have
been included. In December 2003, upon the request of
DG SANCO, the GMO database was also updated with da-
ta from the CODEX Alimentarius database, which in-
cludes methods reported by member countries. The da-
tabase contains now 390 records and more than 600
visitors consulted it during the last three months. This
resource is highly appreciated by a wide range of users
at the international level and by Commission Services.
Indeed it will be included, as a reference link for provi-
sion of information on methods of GMO analysis, in the
Commission Recommendation on technical guidance for
sampling and detection of GMOs, in support to the Reg-
ulation (EC) 1830/2003.
DATABASES AND INFORMATION
TO THE GENERAL PUBLIC
GMO Notifications Summary (SNIF)
Since many years, DG Environment and Member States'
Competent Authorities (CA) have mandated the JRC to
provide electronic means for the exchange of informa-
tion on the Summary Notification Information Format
(SNIF), according to Directive 2001/18/EC which col-
lects all data related to EU deliberate field trials involv-
ing GMOs. An Intranet-based system, called WebSNIF,
has been developed to allow CAs and the European
Commission to circulate the appropriate amount of in-
formation by granting the necessary level of access and
security to each user.
A second function of the system is to provide access to
an open Internet site http://gmoinfo.jrc.it/ from
where, as required by Directive 2001/18/EC, informa-
tion on products approved for products approved for
marketing is published and where the general public
can submit comments. During 2003, the system allowed
the circulation of 82 SNIFs regarding deliberate field
trials, and 23 SNIFs regarding placing on the market.
The statistics of the website reveal that the interest in
the subject is not only limited to the European Union,
as an important percentage of the visits came from out-
side EU. Visits originate from both the general public
and professional/scientific sources.
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* IDA = Interchange of Data between Administrations: IDA is a European Commission driven strategic initiative using advances in information and
communications technology to support rapid electronic exchange of information between Member State administrations. The objective is to im-
prove Community decision-making, to facilitate operation of the internal market and to accelerate policy implementation.
INFORMATION SYSTEMS IN SUPPORT
OF THE REGULATORY PROCESSES
DG ENV has requested the exchange of information be-
tween Member States, the European Commission and
the general public in the framework of Directive 2001/
18/EC regarding:
• Reception, management and on-line publication of
summary notification information describing small
scale field trials;
• Reception, management and on-line publication of all
part C notification dossiers, plus timely handling of
public comments, comments from Member States, re-
quests for additional information, etc.
The support given by the B&GMO Unit has served as an
example for the Biosafety Clearing House under the
Cartagena Protocol and link with other OECD initiatives.
The existence of a single biosafety platform serving the
needs of different pieces of legislation is going to facil-
itate Member States in fulfilling the provision of infor-
mation required by the different legislative tools. Fi-
nancial assistance was requested from IDA* to sup-
port the development of a tracking system, inclusive of
a document management system and a GMO register
(GMOREGEX).
GMOREGEX
The purpose of the GMOREGEX project is to implement
an automated system in support of all activities relat-
ed to the exchange of information between Member
States Competent Authorities, the European Commis-
sion and the general public, as defined in Directive
2001/18/EC. The system will include a register for the
purpose of recording the information on genetic modi-
fications in GMOs, as specified in the Directive. The
system will make use of IDA generic services that have
been implemented for fostering information systems
interoperability through the creation of a coherent
framework, consistent quality assurance standards and
best practices. These services include a pan-European
IP network, similar to the Internet, dedicated to inter-
administrative requirements (TESTA), a communication
and information administration system (CIRCA) sup-
porting the cooperative activity of committees and
working groups, and a PKI (Public Key Infrastructure)
facilitating secure communications and the use of
electronic signatures.
The project started at the end of January 2003. The pre-
paratory phase is now completed, during which a thor-
ough analysis of Directive 2001/18/EC to define the
business process involved in the timed exchange of in-
formation. A system prototype was developed for test-
ing the most appropriate technologies. The next steps
will be the analysis of the documentation format and/or
structure, including a preliminary definition of how the
B&GMOs webpage
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notification dossier should be structured, using syntax
such as XML, in order to ensure efficient handling.
Biosafety Clearing House
The JRC has been nominated as the Biosafety Clearing
House (BCH) Focal Point (FP) for the European Communi-
ty. The secretariat of the Convention on Biological Diver-
sity (the Biosafety Clearing House — BCH) has requested
the expertise of the B&GMOs Unit to support the increase
of inter-operability between the BCH and the information
flow in the EU. Tasks of the EU BCH FP a nation-
al/regional FP include: 1) liaising with the CBD Secretar-
iat regarding technical aspects of national participation
in the Biosafety Clearing-House; 2) validating records at
a national/regional level, making them publicly available
through the central portal, and facilitating the develop-
ment of an interdisciplinary network; 3) coordinating the
distribution of information with Member States FP, which
are also parties to the Cartagena Protocol and have been
nominated a National BCH Focal Point.
The Unit already started the activities in the informa-
tion submission and dissemination and it is currently
organizing the coordination with the MS focal points.
Activities for the next months include the design and
development of a web-based application, conforming
with the technical requirements of the CBD BCH portal
and interoperable with both the CBD BCH portal and the
National BCH FP of the Member States.
RISK PERCEPTION: SCIENCE, PUBLIC DEBATE
AND POLICY MAKING, 4-5 December 2003
Understanding the process(es) of risk perception, and
finding ways to take account of it in policy making so
as to increase the public's trust in science based regula-
tion, has become a political imperative in modern gov-
ernance. Nowhere is this more apparent than in the area
of GM agri-food. This major international conference,
organised on behalf of DG-SANCO, under the Com-
mission’s Life Science and Biotechnology — A strategy
for Europe initiative, and hosted by the European Com-
mission in Brussels, brought together leading interna-
tional experts, key opinion formers, and decision mak-
ers to debate issues surrounding risk, the perception of
risk, and its interplay with the citizen, society and gov-
ernance.  Under the auspices of Mr David Byrne, Europe-
an Commissioner for Health and Consumer Protection, a
wide selection of world experts and international opin-
ion formers addressed some of the finer elements of hu-
man behavioural psychology, such as human behaviour
based on perception, rather than fact, as well as broad-
er sociological considerations such as societal values in
the interpretation of risks and perceived risks, against
the wider dimensions of varying cultural influences,
particularly in relation to GM issues including the need
for  improved management strategies of risks and per-
ceived risks. Over 530 delegates participated over two
days. Copies of the speeches and presentations can be
found on the DG-SANCO website at http://europa.eu.
int/comm/food/risk_perception/index.htm
CONCERTED ACTION: ENTRANSFOOD
(European Network Safety Assessment of
Genetically Modified Food Crops)
In 2000, under FP5, the thematic network European net-
work safety assessment of genetically modified food
crops (ENTRANSFOOD) was launched with the specific aim
of identifying research strategies and tools to address is-
sues related to safety and management of transgenic
food products, and in particular the relationship to test-
ing or assessment of food containing or produced from
GMOs. The Unit was responsible for the co-ordination of
the working group concerning gene transfer in relation to
the safety of food and feed derived from GM-plants. This
working group was further linked to the previous GMO-
BILITY project and concluded in May 2003.
SHARED COST ACTION: QPCRGMOFOOD
(Reliable, standardized, specific, quantitative
detection of genetically modified food)
In 2002 the unit played a central role in the shared cost
action QPCRGMODOOD project, also under FP5, which
aimed at developing reliable and transformation-event-
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specific tests for qualitative and quantitative de-
tection of genetic modifications in food, including
event-specific multiplex tests for determination of
the diversity of genetic modifications in food, and
how the implementation of such methods would
impact on the overall consumer confidence in food
security and trust in science and risk regulators.
The unit was charged with the co-ordination of a
work package dedicated to the validation of all
methods developed in the other work package, in
particular extraction, event-specific detection and
event-specific quantitation. This approach included
responsibility for the designs of the ring-trials,
study organisation, data analysis, evaluation and
eventual method recommendation for application.
The work involved the development of a general
scheme for validation studies, and in the second
half of 2002, reference gene systems for maize, soy-
bean and oilseed rape as well as DNA extraction
methods for different maize and soy matrices were
tested in multi-laboratory validations. In addition,
the pre-validation of nine quantitative GMO-spe-
cific methods was launched. This project concluded
in 2002.
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Institutional Project
The validation of alternative methods
ceva
m
European Centre for the Validation
of Alternative Methods
The European Centre for the Validation of Alternative
Methods (ECVAM) is an international reference centre
for the development and validation of alternative test-
ing methods to replace, reduce or refine the use of lab-
oratory animals in the biomedical sciences with empha-
sis on toxicological assessments.
ECVAM was established by a communication of the Eu-
ropean Commission (SEC 91/1794) referring to a re-
quirement in the animal protection Directive 86/609/
EEC.
ECVAM’s work is focused on the development and evalu-
ation of in vitro methods (e.g. cell and tissue cultures),
the use of computer modelling based on structure-
activity relationships, and on physiological and bioki-
netic modelling.
ECVAM’s role is to co-ordinate international validation
studies, to act as a focal point for the exchange of in-
formation, to set up and maintain a database on alter-
native methods, and to promote dialogue among legis-
lators. Moreover, ECVAM plays an active role in the pre-
normative research activities of the JRC.
Due to the political sensitivity of its duties, ECVAM has
a Scientific Advisory Committee (ESAC) with participa-
tion from all Member States, relevant industrial associa-
tions, academic toxicology, the animal welfare move-
ment, as well as other Commission services with an
interest in the alternatives area.
Consequently, ECVAM has established a wide interna-
tional network of collaborators. ECVAM also works in
close collaboration with other Commission services,
such as DG Environment, DG Enterprise, DG Research
and DG Health and Consumer Protection.
ECVAM AND THE CHALLENGE OF EUROPEAN POLICIES
The new EU Chemicals Policy will require the assessment
of some 30,000 chemicals, which will have serious fi-
nancial and animal welfare implications, unless alterna-
tive methods are developed and validated, and eventu-
ally implemented in the context of the REACH system.
The 7th amendment of the cosmetics directive (Council
Directive 2003/15/EC) foresees phasing out animal ex-
periments within 10 years. Consequently, the overall
aim of ECVAM is to provide support to the future Chem-
icals Policy and Cosmetics Directive through the devel-
opment, validation and promotion of non-animal meth-
ods, especially those designed for the testing of
chemical substances and products (including cosmet-
ics, medicines and biologicals) and biomaterials, and
the operation of specialised databases.
In the light of the recently emerged new expectations
from both the European cosmetics directive and the
chemicals policy, ECVAM has restructured its services by
directly targeting the animal tests to be replaced. 11
key-areas have been established or were reinforced
with the support of various working groups with partic-
ipation of stakeholders and international experts (for
details see the ECVAM website: http://ecvam.jrc.it).
Moreover, in support to the implementation to the 7th
amendment of the cosmetics directive, ECVAM co-
ordinated the creation and operation of ad-hoc interna-
tional working groups to access the state-of-the-art of
alternative methods for human health effects, in sup-
port to a jointly established working group of Commis-
sion services and stakeholders.
ECVAM’S MAIN ACHIEVEMENTS
The following list summarises the most important
achievements since its foundation in 1991.
Validation of alternative methods
to animal experimentation
8 alternative testing methods have been endorsed by
the ECVAM Scientific Advisory Committee as scientifi-
cally valid for skin corrosivity, phototoxicity, embryo-
toxicty testing, as well as for percutaneous absorption
of chemicals. Furthermore, 7 alternative methods
reached scientific acceptance for mainly potency test-
ing and safety evaluation of biologicals, such as vac-
cines, as well as for the production of monoclonal anti-
bodies. A further four cell-based tests successfully
passed the multi-partner validation project on monitor-
ing side effects, such as fever reactions, arising from
contaminants of injectable drugs which could save the
lives of about 200,000 laboratory rabbits per year in
Europe.
The ECVAM validation study to predict adverse effects of
anticancer drugs on the blood forming system, causing
acute neutropenia, has successfully been completed.
The following methods granted regulatory acceptance
by International bodies:
• Reconstituted dermal models (EpiSkinTM and EpiDer-
mTM) and the TER test for skin corrosivity testing and
the 3T3 Neutral Red Uptake for phototoxicity test-
ing. All were accepted by both the European Com-
mission (Annex V to Council Directive on dangerous
substances 67/548/EEC) and the Test Guideline Pro-
gramme of the Organisation of Economic Coopera-
tion and Development (OECD). Furthermore, ECVAM
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actively supported and/or endorsed alternative re-
finement tests for skin sensitisation and acute oral
toxicity testing. After the regulatory acceptance a
50% reduction of animal use for skin sensitisation
and a reduction of animal use by a factor of three
compared to previous test guidelines for acute oral
toxicity was achieved.
• Three potency tests of biologicals have been accept-
ed by the European Directorate for the Quality of
Medicines (European Pharmacopoeia).
ECVAM as a focal point for information exchange
and the promotion of dialogue between all involved
parties in the alternatives area including legislators
Since its foundation, 48 ECVAM workshop reports have
been published in peer-reviewed journals as an out-
come of expert group meetings organised by ECVAM
reviewing the state-of-the-art of non-animal test de-
velopment in various areas. 15 Task Forces were estab-
lished to focus on more tightly defined targets.
ECVAM organised the 3rd World Congress on Alternatives
and Animal Use in Life Sciences, held in Bologna in
1999, with the participation of nearly 800 participants
from 39 countries. It comprised in several plenary lec-
tures, 35 parallel sessions, 26 workshops, four point/
counterpoint sessions and 250 poster presentations.
In 2002, ECVAM organised a Status Seminar with its
collaboration partners and stakeholders to critically re-
view the contributions of ECVAM and to identify priori-
ties for future activities with regard to its four main
tasks and with emphasis on the EU Chemicals Policy,
the 7th Amendment to Directive 76/768/EEC on Cosmet-
ics and Directive 86/609/EEC on animal welfare.
Establishment of a database on alternative methods
ECVAM has established a Scientific Information Service
(SIS), which consists of three projects: databases pro-
viding factual and evaluated information on various
aspects of animal alternatives at any stage of develop-
ment and validation, the international ECVAM Thesau-
rus project and the ECVAM website. SIS went the first
time online in 2001 and has currently 2900 registered
and active users from 65 countries.
In addition, numerous supplementary activities have
been undertaken to comply with ECVAM's overall mis-
sion. Selected key achievements and events are listed
hereafter:
• International harmonisation of the principles for sci-
entific validation of alternative methods (ECVAM
Workshop Report 5. “Practical Aspects of the Valida-
tion of Toxicity Test Procedures”. Balls et al. (1995)
ATLA 23, 129-147).
• International standardisation of laboratory practices
in the field of in vitro techniques through the estab-
lishment of Good Cell Culture Practices (GCCP) along
the principles of Good Laboratory Practice (GLP)
leading to a guidance document on GLP for in vitro
toxicology which were submitted to OECD jointly by
ECVAM and the US Interagency Coordination Commit-
tee on Alternative Methods (ICCVAM).
• 1st Meeting of the OECD Expert Group on (Q)SARs
hosted by the JRC in 2003 to develop a two-year work
programme for the newly established OECD activity
on (Q)SARs, which was approved by the OECD Joint
Meeting the Chemicals Committee and Working Party
on Chemicals, Pesticides and Biotechnology in June
2003. The JRC will play a leading role in its imple-
mentation.
ECVAM’S ORGANISATION: THE 11 KEYS AREAS
Systemic Toxicity (acute and chronic)
Systemic and repeated dose toxicities represent a big
challenge for ECVAM, since in these two fields, only some
reduction or refinement methods have been developed,
i.e. methods, which reduce the number or the suffering
of the animals, but still are animal experiments (e.g. Lo-
cal Lymph-Node Assay for sensitisation). With regard to
animal consumption, the systemic and repeated-dose
tests make up a substantial proportion of all animals
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used. For the first time complex tiered testing strategies
have to be composed and validated. This requires an en-
tirely new toolbox for risk management. This conceptual
framework shall be deduced and elaborated in a series of
consensus workshops. As a consequence, this will be uti-
lised for the key areas of long-term and systemic toxici-
ties in the future (reproductive toxicity, acute, repeated
dose and chronic toxicity as well as carcinogenicity).
A workshop on acute toxicity was held in September
2003 to develop a strategy to replace animal tests in
acute toxicity testing. The recommendations are re-
flected in the Integrated Project Proposal A-Cute-Tox,
which was submitted to DG RTD in November 2003, and
the contract is now under negotiation.
In the specific areas of haematotoxicity and immunotox-
icity the activities are focussed on the optimisation and
validation of in vitro tests for assessing the cytotoxic
effects of chemicals, and on the development of predic-
tion models for extrapolating these effects to predic-
tions of acute lethal toxicity in animals and humans. In
vitro haematotoxicology provides the opportunity to
study the effects of toxicants directly on relevant hu-
man target tissues, reducing toxicological uncertainties
due to animal/human extrapolation, and giving its
knowledge and experience necessary for applying this
kind of model to other continuously renewing tissues in
the body. Moreover, a genetic damage to haemato-
poietic cells may occur in the absence of any overt hae-
matological signs. The development of tissue-specific
screening systems which are able to give information
about toxic effects of chemicals, drugs and environmen-
tal hazards on target genes is needed in order to make
preliminary decisions or set priorities for selection
among large groups of chemicals and possible drugs.
In the area of repeated and chronic toxicity testing in
vitro activities have been started aiming to identify pri-
orities and to start defining a testing strategy. Two re-
search projects to investigate the damage caused by
Ochratoxin A to renal proximal tubules and to evaluate
the usefulness of molecules of plant origin to replace
animal serum in cell cultures were successfully com-
pleted. An FP6 STREP project, PREDICTOMICS, entitled
“Short-term in vitro assays for long-term toxicity” has
been funded by DG RTD and ECVAM is involved in the
Executive board.
In the context of the Cosmetic Directive, estimated
timetables for the provision of alternative methods for
acute, subchronic and subacute toxicity have been pre-
pared.
Topical Toxicity
New activities in the field of eye irritation were initiat-
ed with the scope of achieving the validation of alter-
native methods to replace the traditional Draize rabbit
eye test. They involve:
• The evaluation of the in vivo variability of the Draize
Eye Test, based on literature research and on data
collection.
• The evaluation of alternative methods aiming to re-
fine the existing animal test, such as the Low-
Volume-Eye-Test.
• Data collection and retrospective evaluation of the
most promising in vitro methods that might partially
or completely replace the animal test.
With regard to the ECVAM international validation study
on the EpiDerm and EPISKIN assays and the SIFT for the
prediction of acute skin irritation, the logistics were or-
ganised, contracts were established and test chemicals
selection for phase 1 was completed.
An “ad hoc Group” between Commission services and
stakeholders was set up to establish an objective state
of play for the evaluation of the current status of alter-
native methods/strategies and the prospects for their
validation and regulatory acceptance. Additional scien-
tific experts on the 11 human health effects of concern
were nominated. ECVAM coordinated the scientific dis-
cussion process.
Sensitisation
Exposure to chemicals may result in a variety of allergic
reactions among which allergic contact dermatitis
(ACD) and sensitisation of the respiratory tract are
those of greater importance because of their increasing
prevalence.
In the field of skin sensitisation progress has been
made with the regulatory acceptance of the local lymph
node assay (LLNA). However, the assessment of the
sensitising potential of chemicals and products still re-
lies on animal tests.
A task force on skin sensitisation was established in
2003 to decide on the best way forward in the identifi-
cation of the most relevant endpoints, development,
and pre(validation) of alternative test methods for skin
sensitisation with the ultimate goal to validate a test
strategy for the full replacement of the animal tests. In-
house research activities are planned and a task force on
respiratory sensitisation will be established in 2004.
Carcinogenicity
The detection of carcinogenic chemicals still remains a
challenge, in particular in the case of substances that
act via a non-genotoxic mechanism. To date no in vitro
test that detects non-genotoxic compounds has been
validated and accepted by regulatory authorities.
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The objective of the activity on carcinogenicity is to set
up a testing strategy to pick up genotoxic and non-
genotoxic carcinogens. In the frame of these activities
both 1) classical methods (e.g. cell transformation as-
says and micronucleus test) are currently evaluated for
their validity, and 2) novel technologies, such as toxi-
cogenomics will be used and evaluated.
A taskforce has been created to steer all activities in
this field from the organization of workshops and con-
ferences to the development of collaborative networks
with scientists from academia, industry and regulatory
bodies.
In the context of an integrated strategy based on the
use of cell transformation assay by mouse fibroblast
(Balb/3T3) in combination with genotoxicity in vitro
testing (Micronuclei and Comet assays) extensive re-
search work is ongoing, especially in the area of metal
carcinogenicity. Moreover, ECVAM has started to explore
in house and through collaborative studies the molecu-
lar signatures of a set of key carcinogenic chemicals,
using both murine and human cells as target.
Reproductive Toxicity
ECVAM has finalized its activities in the area of using
genetically engineered murine embryonic stem cells for
the detection of teratogenic compounds. ECVAM is now
focusing on the establishment of human embryonic
stem cell technology in its laboratories. The potential
of human embryonic stem cells to differentiate into all
kind of cell types of the human body offers the unique
opportunity to develop humanized in vitro tests which
will avoid interspecies variations and will therefore en-
hance the predictivity of safety toxicological tests.
In addition, ECVAM has taken the lead to establish a
consortium of about 30 partners to develop in vitro tests
that can be used as building blocks in future testing
strategies with the aim to detect reproductive toxicants.
The integrated project proposal (ReProTect) has been
granted by DG RTD and started on the 1st of July 2004.
ECVAM has strengthened its activities in the area of en-
docrine disrupters. A task force has been established
and the ongoing OECD validation study on the Hersh-
berger tests as well as the finalized validation study of
the uterotrophic tests have been peer reviewed. EC-
VAM’s reports have been submitted to the OECD.
(Pre)validations of in vitro and in silico alternatives are
under preparation.
Toxicokinetics
Barrier function is an important determinant of absorp-
tion and distribution of compounds within the body. In
vitro models are under evaluation to assess the passage
of chemicals across biological barriers. A study on the
standardisation of an in vitro model of intestinal barrier
function has finished. An ongoing PhD study is devel-
oping and refining a test system for the blood-brain
barrier (BBB).
A PhD project in the area of BBB is evaluating the pos-
sible replacement of primary glial cells in the current
co-culture in vitro model by a glial cell line. The damage
induced by lipoteichoic acid (LTA), which is involved in
the pathogenesis of the bacterial meningitis, on BBB is
also studied.
Ecotoxicology
As a follow-up of the ECVAM workshop on the use of fish
cells in ecotoxicology (report 48 published in 2003),
ECVAM created the new key area ecotoxicology and es-
tablished a steering group, which at present focuses on
reviewing the status of currently available in vitro sys-
tems with regard to their development and/or readiness
for prevalidation/validation. Whether in vitro tests em-
ploying fish cells could replace the acute fish test, or at
least reduce the number of fish needed, is being inves-
tigated.
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Cell transformation assay ‘Arsenito’
Human neurons cultured at ECVAM
Quantitative Structure Activity Relationships (QSARs)
Under current EU legislation for chemicals and chemi-
cal products, the use of (Q)SARs is limited, mainly be-
cause there has been disagreement in the scientific
and regulatory communities over the applications of
(Q)SARs, and the extent to which QSAR estimates can
be relied upon. However, under the REACH (Registra-
tion, Evaluation and Authorisation of CHemicals) sys-
tem, proposed initially in the Commission’s White
Paper on a Future Chemicals Policy and subsequently in
the Commission’s legislative proposal of 29 October
2003, it is anticipated that (Q)SARs will be used more
extensively, in the interests of time- and cost-
effectiveness and animal welfare. In particular,
(Q)SARs are likely to play an important role in the as-
sessment of chemicals produced or imported in quanti-
ties between 1 and 10 tonnes, for which minimal ani-
mal testing is foreseen.
In 2003, the JRC established networks of collaborators
in the (Q)SAR field, and contributed to the OECD Activ-
ity on (Q)SARs, especially in relation to the evaluation
of principles for the development and validation of
(Q)SARs. The JRC was also involved in hosting the first
OECD Workshop on (Q)SAR in March and in the scienti-
fic organisation of an OECD Workshop on the Develop-
ment and Use of Chemical Categories in the HPV Chemi-
cals Programme, which was held in Brussels in January
2004.
Biologicals
Biologicals are products such as vaccines, immunosera,
immunoglobulins, hormones, monoclonal and polyclo-
nal antibodies, which undergo extensive quality control
during their production often involving tests on ani-
mals.
In 2003, the work on Three Rs approaches in the quality
control of biologicals was continued and several work-
ing groups were established (steering group on biolog-
icals, task forces on pyrogenicity and shellfish toxin
testing). Three alternative methods for the potency
testing of human tetanus vaccine and erysipelas vac-
cine, which have been validated in cooperation with
other organisations, have been accepted by the regula-
tors and incorporated into the European Pharmacopoe-
ia. After successful finalisation of the validation study
on in vitro methods for pyrogenicity testing a press
conference was held and the compilation of the dossi-
ers for the peer-review process was initiated. The work-
shop report on Three Rs approaches in the quality con-
trol of rabies vaccines was published. ECVAM continued
to submit comments on revision proposals of European
Pharmacopoeia monographs and European guidelines to
promote the Three Rs concept in the quality control of
biologicals.
In the field of biologicals ECVAM mainly collaborates
with the competent authorities of the EU Member
States, the European Pharmacopoeia, industry, and the
Advisory Group on Alternatives to Animal Testing in Im-
munobiologicals (AGAATI).
Strategic Developments
ECVAM has taken a leading role in safeguarding quality
control for in vitro studies including the application of
the principles of OECD Good Laboratory Practice (GLP)
to in vitro toxicological studies. In May 2004, the OECD
Joint Meeting has approved the Advisory Document on
“The Application of the GLP Principles to in vitro
studies”. Furthermore, ECVAM pursues its activities to-
wards Good Cell Culture Practice (GCCP) guidelines, in
order to reduce uncertainty in the development and ap-
plication of in vitro procedures, by encouraging the es-
tablishment of principles for the greater international
harmonisation, rationalisation and standardisation of
cell and tissue culture based laboratory practices. EC-
VAM has recently published in (December 2002) a task-
force report and is now preparing a Guidance Document
on GCCP.
Toxicogenomics will be exploited as a second genera-
tion of alternatives and will be applied mainly in areas
where no satisfying alternatives exist. A workshop on
the principles of validating toxicogenomic approaches
was held in December 2003 and a pilot in vitro study in-
volving industry and a technology provider was carried
out to identify the potential of these technology meth-
ods for regulatory purposes when applied to in vitro bi-
ological systems on carcinogenic substances.
Another challenge will be to use automated cell and tis-
sue approaches. A concept to set up an automated in
vitro test laboratory for acute toxicity testing (also part
of the Integrated Project A-Cute-Tox) has been devel-
oped, which shall in conjunction with a depository of
chemicals allow to produce larger standardised data
sets on in vitro toxicology systems as well as optimise
the performance of all tests.
Scientific Information Service (SIS)
In line with its institutional duties, ECVAM maintains a
scientific information service (http://ecvam-sis.jrc.it,
SIS) to disseminate factual and evaluated (ready-to-
use) information on advanced alternative methods for
toxicology assessments. In addition to the SIS databas-
es, as the core application, SIS includes the ECVAM The-
saurus and the ECVAM website.
The year 2003 has seen a considerable increase in the
total information content of the SIS databases, dou-
bling the information compared to 2002. The USA, UK
and India are currently the biggest customers of SIS.
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The ECVAM Thesaurus, a systematic collection of harmo-
nised terms in the animal alternatives area, is a result
of a collaborative project with the US National Library
of Medicine (NLM). Online distribution is expected in
2004.
The ECVAM website became an interactive information
service in 2003 supporting the management of interna-
tional meetings organised by ECVAM and it has been
complemented with an easy-to-use registration proce-
dure that allows external interested parties to be regu-
larly updated on the latest news of ECVAM.
NETWORKING
ECVAM established 11 key areas directly targeting the
animal experiment to be replaced with the support of
international working groups with participation of
stakeholders and international experts.
ECVAM collaborates in 15 Networks in the form of Task
Forces on Acute fish toxicity, Biocompatibility testing,
Blood-brain barrier, Carcinogenicity, Endocrine Dis-
rupters, Good Cell Culture Practice, High-throughput
screening, Metabolism, Neurotoxicity, Pyrogenicity,
(Q)SARs, Sensitisation, Shellfish toxin testing, Skin Ir-
ritation, Toxicogenomics and Biologicals. In total, 99
members from 14 countries (distribution see the figure)
are collaborating and disseminating information on
tightly defined tasks.
The activities on in vitro tests and QSARs involve, fur-
thermore, consultation with, and dissemination of in-
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INVITTOX Protocols
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Test Compounds
Test Results
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formation through, the following networks: OECD Net-
works (the OECD Expert Group on (Q)SARs, the OECD
Validation Management Group For Non-Animal Testing
(VMG Non-Animal), the OECD Existing Chemicals Task
Force, the OECD Working Group of National Coordinators
of the Test Guidelines Programme, the OECD Joint Meet-
ing of the Chemicals Committee and the Working Party
on Chemicals, Pesticides and Biotechnology. Further-
more, a close collaboration with the American counter-
part ICCVAM was set up including a mutual observer sta-
tus and various joint workshops, taskforces and studies.
Enlargement
ECVAM organised a practical training course on in vitro
methods for pyrogenicity testing in Hungary and a
workshop on alternatives to the use of animals in high-
er education in Poland.
Two PhD students from Candidate Countries are current-
ly working at ECVAM on the development of structure-
activity relationships for pharmacotoxicological end-
points and on the development of in vitro testing meth-
ods for assessment of neurotoxic and neurodegenera-
tive potential.
A scientist from Poland worked at ECVAM for a period of
six months in the key areas Systemic Toxicity and Stra-
tegic Developments.
Patent
EP patent application on “Functionalization of intracor-
onary stents” (EP n° 02292525.9)
Competitive Activity
Participation in the Executive board of PREDICTOMICS
(STREP project “Short-term in vitro assays for long-term
toxicity”).
Two applications for Integrated Projects were steered
by ECVAM (A-Cute-Tox and ReProTect) and will start in
2004.
Prizes / Awards
Thomas Hartung was granted a honorary professorship
at the University Konstanz, Germany and the Award for
Environment and Society by LBS Baden-Württemberg,
Germany.
The US Environmental Protection Agency (EPA) has
nominated Andrew Worth as an expert consultant in a
newly-established Panel of the EPA Scientific Advisory
Board on Computational Toxicology.
ECVAM Workshops & Task Forces
In 2003, ECVAM organised eight meetings on Biologi-
cals, Endocrine Disrupters, Good Cell Culture Practice
(GCCP), Metabolism, Neurotoxicity, Pyrogenicity, Sensi-
tisation and Skin Irritation. Five workshops were held
on the Validation principles for toxicogenomics-based
test systems, Strategies for non-animal acute systemic
toxicity testing, Possible applications of in vitro blood-
brain barriers models, Skin irritation validation study
and In vitro systems for evaluating immunotoxicity.
Furthermore, international working group meetings
were organised for the purpose of the Cosmetics Direc-
tive.
Two reports of ECVAM workshops on ecotoxicology and
the quality control vaccines were published.
Major Events
The 1st Meeting of the OECD Expert Group on (Q)SARs
was organised and hosted by the JRC in March 2003.
During this meeting, a proposal was developed for the
QSAR Activity. It was adopted in June 2003 by the OECD
Joint Meeting of the Chemicals Committee and Working
Party on Chemicals, Pesticides and Biotechnology.
Image from the Pyrogenicity study
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Press Conferences
In a press conference in May 2003 European Commis-
sioner for Research Philippe Busquin presented the re-
sults of the EU-funded validation study that demon-
strated that a few human blood cells are able to
eliminate animal testing for parenteral (non-oral)
drugs. In collaboration with DG Research ECVAM has
successfully evaluated six blood cell methods for moni-
toring side effects such as fever reactions arising from
contaminants of injectable drugs. This could avoid the
need to test on about 200,000 laboratory rabbits per
year in Europe.
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European Chemicals Bureau
The ECB provides scientific and technical support to the
conception, development, implementation and moni-
toring of EU policies on dangerous chemicals. The aim
of the legislation is to ensure a high level of protection
for workers, consumers and the environment against
dangerous chemicals and to ensure the efficient func-
tioning of the internal market on chemicals under the
current Community legislation. The ECB ensures the de-
velopment of methodologies and software tools to sup-
port a systematic and harmonised assessment of chem-
icals addressed in a number of European directives and
regulations. The activities of the ECB are executed in
close co-operation with the relevant authorities of the
EU Member States and Norway, Commission services
(such as DG Environment and DG Enterprise), the chem-
ical industry, the OECD and other international organi-
sations, and NGOs.
REACH
The IHCP has responded to the needs set out by the
REACH (Registration, Evaluation and Authorisation of
CHemicals) system. The European Chemicals Bureau
(ECB) contributed extensively to the drafting of the
REACH legislation, specifically the technical annexes.
The ECB also produced an important report on the test-
ing needs under REACH and on the role of (Q)SARs
(Quantitative Structure Activity Relationships). (Q)
SARs can play an important role in reducing the testing
needs (and costs) for industry under the future REACH
legislation. An international workshop on the scientific
aspects of REACH was organised in December, 2003 by
IHCP.
CLASSIFICATION & LABELLING
The ECB is in charge of the technical and scientific is-
sues for Adaptations to Technical Progress (ATP) of An-
nexes I, II, III, IV, VI and IX to Council Directive
67/548/EEC on the classification, packaging and label-
ling of dangerous substances. The work comprises
mainly of the preparation, chairing and follow-up of the
meetings of the Commission Working Group on Classifi-
cation and Labelling, co-ordination between Member
States and Industry of discussions and activities be-
tween meetings, and providing information to other
Commission Services.
The single most important achievement of the work on
C&L was the preparation of the draft 29th Adaptation to
Technical Progress to the Directive including an update
of the list of classified substances in Annex I, which
was sent to DG ENV at the end of the year. It contained
about 900 revised or new entries to Annex I.
General issues discussed by the Working Group during
the year:
• Discussion on the New Chemicals Policy and the pos-
sible implementation of the Globally Harmonised Sys-
tem (GHS) on classification and labelling.
• How to work during the interim period.
• Discussions on parental toxicity in relation to fertility
and developmental effects
• Testing the GHS criteria for classification and label-
ling for substances classified under the current sys-
tem.
• Haemolytic effects related to classification with R48.
• Classification of substances that may emerge as aero-
sols.
• Continued discussion on potency of sensitising sub-
stances.
• Issues concerning the 29th ATP.
• Classification of metals and metal compounds from
the ESR programme.
• Specific concentration limits for environmental clas-
sification.
About 40 substances were evaluated in the Pesticides
group for health effects and about 30 substances were
evaluated for environmental concerns.
EXPORT / IMPORT
The ECB fulfils the duties of the Commission within the
export notification process as laid down in Regulation
(EEC) 304/2003. It gives technical and scientific sup-
port for the implementation of the Regulation, which
aims at:
1 Implementing the EU export notification procedure,
2 Making the voluntary UNEP/FAO Prior Informed Con-
sent (PIC) procedure legally binding within the Com-
munity and
3 Using the same rules for classification, packaging
and labelling outside the Community that apply in
the internal market.
162 export and import notifications were carried out in
accordance with the new Regulation that entered into
force in February 2003. The European Database on Ex-
port and Import – EDEXIM was upgraded to meet the re-
quirements of the Regulation. The ECB continued to
contribute to a project to create an international plat-
form for capacity building, mainly based on Internet
applications under the IFCS.
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TESTING METHODS
The ECB is responsible for the technical/scientific work
needed for the development, introduction and adapta-
tion to technical progress (ATP) of testing methods of
Annex V to Dir. 67/548 (and its adaptations).
In order to ensure a harmonisation of test methods in
as a wide international context as possible, according
to the principle of Mutual Acceptance of Data, the Com-
mission participates in the OECD Test Guidelines Pro-
gramme by promoting and proposing the development
and adoption of new Test Guidelines needed under EU
legislation on chemicals control. Subsequently, adopt-
ed guidelines are adapted and introduced into Annex V.
The ECB coordinated the introduction of projects for
two new guidelines in the OECD Programme in 2003. In
addition, the preparatory work for the foreseen 29th ATP
has continued and thirteen methods (including transla-
tions to all official languages) were provided to DG En-
vironment. First drafts in Annex V format of several ad-
ditional methods were prepared. Complete final ad-
option in OECD is, however, necessary before proceed-
ing to finalise them and subsequently circulate them to
the National Coordinators for comments and agree-
ment.
NEW SUBSTANCES (Directive 67/548/EEC)
Over 6000 notifications in total, including nearly 4000
new chemical substances, have been submitted since
1983, in the recent years equivalent to 350–400 notifi-
cations and 250–300 substances per year. Irrespective
of notification date, in the last years a similar number
of notifications have been processed annually by ECB
(in 2003: 879 dossiers, comprising 493 notifications
and 386 updates). High priority was given to availabil-
ity of information via the ECB internet pages. A 7th edi-
tion of ELINCS (European LIst of Notified Chemical Sub-
stances) in English has been made available through
the ECB Web site.
EXISTING SUBSTANCES
The Regulation 793/93 foresees that the evaluation
and control of the risks posed by existing chemicals,
i.e. the ones listed in the European Inventory of Exist-
ing Commercial Substances (EINECS), an inventory con-
taining 100,106 substances, will be carried out in four
steps: (1) data collection, (2) priority setting, (3) risk
assessment and (4) risk reduction. In providing scien-
tific support to the implementation of the Regulation,
the ECB aligns its work with the strategy for implement-
ing an environmentally sound management of toxic
chemicals outlined in Chapter 19 of the Agenda 21 Rio
Declaration, adopted at the UNCED in 1992, and reaf-
firmed in Johannesburg 2002. On the international lev-
el, the ECB is thereby responsible for scientific and
technical inputs to the OECD existing chemicals pro-
gramme and several UN initiatives on chemicals.
By the end of 2003, the total number of EU high produc-
tion volume substances is 2747, this is an increase of 43
HPVs over the previous year. The total number of low
production volume chemicals is decreased from 7842 to
7829, as a result of 13 becoming categorised as HPVs.
In 2003, all the non-confidential data were placed on
the ECB Website in downloadable IUCLID pdf format. In
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addition, the full IUCLID (International Uniform Chemi-
cal Information Database) installation (software, Oracle
licence and data CD) was distributed to the nominated
Authorities in the 10 EU Accession States. Furthermore,
user requirements for IUCLID 5.0 were developed and
work on defining the technical specifications of the
software started in 2003 in order that programming can
commence in 2004. In addition, the ECB contributed to
the development of the global portal for exchange of
data on HPV chemicals under the auspices of OECD in
the frame of an EU/US initiative. In support to the EU
enlargement, a IUCLID course was given in October
2003 in Bratislava (Slovakia). The course was highly
appreciated by the participants from the competent au-
thorities in the new Member States. More courses are
scheduled in 2004. In order to facilitate the correct use
of IUCLID 4.0, Guidance Documents are being drafted in
the frame of a joint collaboration with CEFIC.
In terms of priority setting, during 2003, our work on
identifying potential Persistent, Biocumulative and
Toxic substances continued. Potential PBTs were evalu-
ated by a Member State, industry and NGO Expert Work-
ing Group over 3 meetings hosted and chaired by ECB.
Substance fact sheets were updated with additional in-
formation provided in the main by Industry. Substances
were either verified as PBT/vPvB, deleted from the list
or identified as requiring further testing. This work will
continue in 2004.
In April 2003, under the OECD/JRC cooperation the ECB
hosted the first meeting of the Ad-hoc expert group on
Quantitative Structure-Activity Relationships ((Q)SARs).
In relation to the increased emphasis on QSAR develop-
ment and validation under REACH the QSAR activity was
re-established in 2003 in ECB as Key Action under the
EU 6th Framework Program of Research. This activity was
transferred to ECVAM mid year, but the ECB maintained
and will continue to maintain close links with the activ-
ity in 2004 in preparation of guidance documents on
testing requirements for REACH. ECB participates in the
OECD Expert Group on (Q)SARs and the ECVAM Task
Force on QSARs.
The main results regarding risk assessment by the ECB
are summarized here below:
• Discussions were started on 21 substances at Technical
Meeting (TM) level
• Discussions were completed on 5 substances at TM level
• Draft reports were finalised on 16 substances and sent to
CSTEE
• RARs on 15 substances were published on the ECB Web-
site (modification in the light  of CSTEE opinion, format-
ting and editing)
• The preparation for publication of the results of the work
of the TM in one Commission Recommendation and a
Commission Regulation on testing requirements under
Article 10.2.
Significant effort has been made to upgrade and main-
tain up-to-date Web-based communication via the ECB
web site. All the online information can be found via
the following URL address: http://ecb.jrc.it. The ECB
Website is now well known and the 35 M monthly visit-
ed pages as well as the 2000 unique users/day are
reached.
BIOCIDES (Directive 98/8/EC)
The ECB is in charge of the scientific and technical is-
sues raised in the approval of active substances in bio-
cidal products as laid down in Directive 98/8/EC. For
2003 the main task has been to complete the notifica-
tion phase, which is the basis for Annex II of the Sec-
ond Review Regulation.
The evaluation of the active substances will start in
2004 and, including 2003, the main tasks of the work
area have been to give support to the Competent Au-
thorities on the guidance documents for the implemen-
tation of the Directive and priority setting in the review
programme. These tasks will continue, but the emphasis
will change in the direction towards harmonisation of
the evaluation process for the substances in the review
programme.
The work area acts as a Help-Desk for the Biocides Di-
rective and the Review Regulations where there is a
growing need for information and the work area has
daily telephone and e-mail information requests to an-
swer.
Results of the categorisation of the 94 substances
on the potential list of PBTs
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In preparation of the review programme the following
tasks were undertaken in 2003:
• The final lists of all existing active substances used for
biocidal purposes were generated as well as the list of
notified substances and product types. These lists are
the main content of the 70 pages annex to the second
review regulation that was published in the Official
Journal of the European Communities 3rd November
2003. Rapporteur member states were allocated to sub-
stances on the first two priority lists.
• The User’s guidance for the TNsG on Human Exposure to
in Biocidal Products was progressed and is expected to
be finalised early 2004.
• The Technical Guidance Document on Risk Assessment
was published.
• The Emission Scenario Documents (ESD) for product
type (PT) 5 (Drinking water disinfectants), PT 10 (Ma-
sonry preservatives), PT 11 (Preservatives for liquid
cooling systems), PT 12 (Slimicides), PT 13 (Metal
working fluids), PT 14 (Rodenticides), and PT 15 (Avi-
cides) were finalised.
• A course on using the ESD for Wood Preservatives and
Rodenticides was held for the authorities of the mem-
ber states.
• The working group on data requirements and testing
strategies held its first meeting resulting in better-
defined specific data requirements for rodenticides, es-
pecially regarding the long-term tests for anticoagu-
lants.
• A course on IUCLID targeting the accession countries
was held.
• The biocides team participated in numerous events and
conferences aiming at explaining the Biocides Direc-
tive, the first and second review regulations and conse-
quences.
• The web page for Biocides, http://ecb.jrc.it/biocides,
has continuously been up-dated, to enable industry to
check that their information is registered correctly and
to distribute information to third parties.
For the Biocides, a detailed description of Exposure
both for the Environment and for Humans is crucial for
the understanding of the risk. In order to assure ade-
quate guidance on this matter DG ENV tendered for a
continuation of the project on environmental exposure
scenarios, EUBEES. The EUBEES II project held 3 meet-
ings during 2003 where draft reports on development,
harmonisation or testing of Emission Scenario Docu-
ments for a number of product types were evaluated.
The user’s guidance report on models for human expo-
sure to active substances in biocidal products was fur-
ther progressed.
Main achievements in 2003:
• The Second Review Regulation (RRII), Regulation (EC)
No. 2032/2003, was published.
• Update of the TNsG on data requirements for PT 14 (Ro-
denticides).
• The TGD revision for the Risk Assessment of New Noti-
fied, Existing Substances and Biocides was published.
• For the Environmental Exposure, EUBEES II was final-
ised, resulting in Emission Scenario Documents for 7
more product types.
• Biocides Notification and Identification Scheme: Regu-
lation EC No. 1687/2002, with a legal deadline of 31
January 2003, resulted in about 50 additional notifica-
tions which were loaded into the database and
checked, and subsequently registered in the list of no-
tified substances in RRII where relevant.
• The allocation of Rapporteur Member States for the 1st
and 2nd priority lists was finalised, and the allocation
for the 3rd and 4th priority lists has been initiated.
• Further development of the formats for submission of
Robust Study Summaries based on the TNsG on Dossier
Preparation for biocidal active substances and biocidal
products were initiated.
• The ECB has carried out 2 training courses one regard-
ing Emission Scenarios for Rodenticides and Wood pre-
servatives, and one IUCLID course for the accession
countries.
COMPETITIVE ACTIVITIES
OMNIITOX project
(EC project number: G1RD – CT2001 – 00501)
The project OMNIITOX (Operational Models aNd Infor-
mation tools for Industrial applications of eco/TOXico-
logical impact assessments) aims to enhance the capa-
bility of industry to select more environmentally benign
chemicals and processes. A feasibility study on intro-
ducing elements and concepts of the Life Cycle Analysis
framework into the regulation of chemicals has taken
shape during 2003.
ECICS – European Customs Inventory of Chemical
Substances (TAXUD/2002/DE/305)
Directorate General for Taxation and Customs Union (DG
TAXUD) and the JRC have established the ECICS feasi-
bility study. The ECICS database compiles international-
ly marketed chemicals in an unequivocal manner for
customs and legal purposes. It contains about 35,400
chemical names (corresponding to approximately
28,600 chemicals) in the 11 Community languages,
with the customs classification in the CN, the CAS
number and the CUS (Customs Union and Statistics)
number. The ECICS feasibility study started in October
2003 and will assess the feasibility of updating the
ECICS database.
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The Unit provides scientific understanding, information
and assessment tools to support the Commission servic-
es in evaluating and quantifying human exposure and
risk assessments for environmental stressors. Stressors
include chemicals, UV-radiation, electromagnetic fields
and noise.
There is clear evidence among experts and policy mak-
ers that the lack of human exposure data represents a
major bottleneck in the risk assessment process. This
has also been recognised by the EU Council of the Envi-
ronmental Ministers, which requested the EU Commis-
sion to undertake action for eliminating existing defi-
ciencies in exposure data. Responding to this challen-
ge, the overall objective for the PCE Unit is to develop
infrastructure, tools and reference data to enable har-
monised exposure assessment procedures in the EU,
and to support the implementation of key policies and
directives, such as:
• New Chemicals Policy: REACH (Registration, Evalua-
tion, Authorisation of Chemicals)
• General Product Safety Directive (GPSD) (2001/
95/EC)
• Food contact materials (e.g. 82/711/EEC, 85/572/
EEC, 89/109/EEC, 90/128/EEC, 93/11/EEC, 2001/61
/EC, and related amendments)
• Textile fibres (96/74/EC, 97/37/EC, 96/73/EC, 73/44
/EEC)
• EU Tobacco Directive (2001/37/EC)
• Indoor exposure limits for priority pollutants (INDEX)
• Authenticity of wines (EC regulation 2729/2000,
Regulation (EEC) N° 2081/92, Regulation (EEC) N°
2082/92, EC Reg N° 2870/2000, EC Reg N°440/
2003)
• Noise Directive (2002/49/EC)
During the last five years exposure assessment to chem-
icals and physical stressors and in particular, the char-
acterisation and estimation of emissions and the re-
lease/migration of chemicals from consumer products
and food contact materials has received much atten-
tion. The PCE Unit has focused its activities on the fol-
lowing areas:
• Sources and Routes of Exposure to Chemicals and
Physical Agents
• Consumer Exposure Modelling
• In vivo / In vitro Evaluation of Effects
• Modelling of Noise Propagation
• Establishment of an Information System on Electro-
magnetic Fields and
• UV Radiation Measurements
In line with the priorities of FP 6 and in support to
Commission services the Unit has developed for the pe-
riod 2003-2006 three actions:
1 Total Human Exposure Assessment Studies (THEX-
AS Chem) The objective of THEXAS chem is to evalu-
ate the risk for European citizens deriving from the
overall exposure to chemicals through different
routes (air inhalation, skin contact etc.) occurring in
indoor and occupational environments.
2 Total Human Exposure Assessment Studies (THEX-
AS Phys) THEXAS Phys has the objective to evaluate
population exposure to physical agents (UV-radia-
tion, noise, electromagnetic fields-EMF) and
3 European Office for wine, Alcohol and Spirit
Drinks (BEVABS) BEVABS manages the European Da-
ta Bank on authentic European wines (EC regulation
2729/200) and to coordinate the Network of official
Member States laboratories involved in Nuclear Mag-
netic Resonance (NMR) determinations required for
the databank. In the past years, BEVABS has carried
out the development and validation of the method
for the determination of the 13C/12C isotope ratio of
ethanol, which has been adopted at International
level by the Office International for Wine and Vine
(OIV) and in March 2003 as official method by the
European Union (EC Reg 440/2003). A scientific
highlight of 2003 was the second International Sym-
posium on Isotopomers (ISI 2003, http://ihcp.jrc.
cec.eu.int/EVENTS/ISI2003/isi2003.html).
The integration of the activities of these actions into a
coordinated work-program allows the PCE Unit to apply
a holistic approach to human exposure, i.e. estimates
and assessment via different routes of exposures to
chemicals and physical agents as the basis for the de-
velopment and implementation of a “European Expo-
sure Assessment Toolbox”, which includes:
• common measurement methods and protocols,
• reference exposure data (chemicals/agent specific),
• reference exposure factors (non-chemical specific,
such as anthropometric data, time/activity patterns,
etc.),
• reference exposure-associated health data,
• common exposure models,
• exposure assessment guidance documents,
• reference exposure scenarios.
The “European Exposure Assessment Toolbox” offers the
emerging “REACH Implementation Plans” (RIPs) initial
pilot exercises and support on downstream user issues.
Physical and Chemical Exposure Unit (PCE)
ACTION THEXAS CHEM
The EU Environment Council has put forward a request
to the European Commission to undertake action for
eliminating existing deficiencies in data on human ex-
posure to chemicals. In this light, JRC is developing
methods and tools to accurately evaluate the risk for
European citizens deriving from the overall exposure to
chemicals through different routes (food intake, air in-
halation, skin contact, etc.) occurring in indoor and oc-
cupational environments. In the frame of this action
human exposure is seen a holistic approach, which in-
cludes estimates and assessment of exposures to chem-
icals released from products and articles (e.g. VOC,
phthalates, biocides, dyes etc.) as the basis for the de-
velopment, testing and implementation of:
• Common measurement methods and protocols
• Common exposure models
• Exposure assessment procedures and tools
• advanced biomarkers/metabonomic exposure analy-
sis and assessment concepts,
• potential interactions of “physical/chemical cock-
tails”.
The work will be carried out in dedicated laboratories of
the PCE Unit specialised in the different types of ana-
lytical tools, exposure set-ups and exposure pathways
to chemical and physical agents:
• Indoortron Laboratory: mainly inhalation exposure
research
• Migration research / contact materials Laboratory:
mainly oral and dermal exposure research
• Toxicogenomics Laboratory: chemical mixtures /
cocktails / biomarkers research
• Action THEXAS phys UV (and Noise) Laboratories:
cocktails research in co- operation with the toxicog-
enomics laboratory
• BEVABS/NMR laboratory: biomarkers / metabonomics
research in co-operation with the toxicogenomics la-
boratory for characterising relevant arrays of biomar-
kers for specific exposures.
These laboratories are being developed to act in their
respective areas as Reference Laboratories at EU level
to improve the currently achievable quality and compa-
rability of measured/modelled data related to consumer
and occupational exposure. In particular, there is a spe-
cific request by DG SANCO to further develop the Migra-
tion research / contact materials Laboratory into a CRL
in the area food contact materials.
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The European Exposure Assessment Toolbox
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In 2003, the following activities / projects were carried
out:
EIS-ChemRisks / ChemTest
The objective is to support the im-
plementation of the General Pro-
duct Safety Directive and REACH
by developing exposure assess-
ment tools and reference data. To
this end, a key activity in 2003
was the prototyping of the “Euro-
pean Exposure Assessment Toolbox” on the example of
chemicals released from consumer products and arti-
cles. A prototype version was released. Main results of
the project were presented in a dedicated workshop or-
ganised by the International Society for Exposure
Assessment, ISEA 2003. Testing of the toolbox has been
started on a sectorial basis, on textiles, toys and per-
sonal care products. Within this frame, policy options
on the safety of tattoos and piercing were presented to
DG SANCO.
(See project reports in http://139.191.172.32/eis-
chemrisks/documents.cfm).
Harmonisation and validation
of consumer exposure models
This activity acts as an interface for other important
European projects, such as the CEFIC/LRI Exposure Fac-
tors Sourcebook project co-ordinated by KTL (Finland),
the JRC EIS-CHEMRISKS project (funded by DG SANCO)
and the CONSEXPO and EUSES projects. The ultimate
goal is to harmonise and validate existing consumer ex-
posure models with particular focus on those used in
the EU, in particular
• to make an inventory of existing exposure models
(with special focus on consumer exposure models)
• to identify harmonisation and validation needs for
these models and
• to proceed with the harmonisation and validation of
an appropriately selected subset of models based on
well established specific exposure factors, data and
scenarios.
In 2003 the Consumer Exposure Modelling Task Force
(CEM TF) established a web-based inventory of existing
exposure models http://cem.jrc.it/cemdb/ with par-
ticular emphasis on consumer exposure models. This
database was created on the basis of model fact sheets
that have been prepared on the basis of information
collected from different sources in EU and USA concern-
ing: (a) existing exposure models; (b) exposure studies
in EU/USA and models employed in them and (c) de-
gree of exposure models verification and validation.
Food Contact Materials / Migration Processes
The activities on migration of chemicals from materials
focus on experimental approaches to produce reliable
data for exposure assessment and pre-normative pur-
poses. They include development, comparison and vali-
dations of methods, exploratory research, monitoring
surveys at EU level to quantify contaminants, databases
on migrants and dissemination of information via web-
sites, courses, and expert workshops.  The work is per-
formed in close collaboration with DG SANCO and DG
ENTR, and fosters excellent contacts with international
research organisations and concerned industries. The
policies supported are on food contact materials (e.g.
82/711/EEC, 85/572/EEC, 89/109/EEC, 90/128/EEC,
93/11/EEC, 2001/61/EC, and related amendments),
toys (1999/81/EEC, 76/769/EEC, 88/378/EEC, 92/59/
EC), and textile fibres (96/74/EC, 97/37/EC, 96/73/EC,
73/44/EEC). The main achievements in 2003 are sum-
marized in the following:
• In 2003, the structural development of the CRL con-
tinued with a focus on the quality program, which in-
cludes ISO 17025 accreditation and participation in
proficiency tests on migration since 1997. The ac-
creditation ISO 17025 first obtained in January 2003
was extended to another method.
• A stability study of Certified Reference Materials 537,
538, and 539 was completed for the Institute for
Reference Materials and Measurements (IRMM). The
results following ISO 17025 protocol for overall mi-
gration in olive oil by total immersion for 10 days at
40°C showed the continued adequacy of the CRMs.
• The results of the European Survey on migration lev-
els of epoxidised soybean oil (ESBO), a plasticiser
from closure gaskets from baby food jars was pub-
lished and led to a request from the European Food
Safety Authority (EFSA) to conduct the exposure as-
sessment. The methodology developed for chlorohy-
drin-derivatives of ESBO in gaskets is being opti-
mised for foodstuffs.
• Exploratory research in 2003 also focused on active
packaging, which can interact with the internal gas
environment to extend the shelf-life of a food. An in-
vestigation on industry prototypes is on-going with
a focus on interactions and migration issues between
these materials and food matrices.
• The work within the frame CEN TC194 (materials and
articles in contact with food) continued. The work-
ing group on coatings has been conducting a valida-
tion trial, whereas the task group on amines is de-
veloping a confirmation method for the quantifica-
tion of primary aromatic amines from multilayer ma-
terials.
• A new project was initiated in 2003 on behalf of DG
ENTR to validate methods related to new generic
names for textile fibres. The pre-validation of a me-
thod for the identification and quantification of a
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new generic fibre polylactide was completed and
showed adequacy.
• Horizontal collaborations with the project EIS-CHEM-
RISKS have been initiated for textiles and toys.
• Events in 2003 included hosting the meeting of all
working groups of CEN TC 194, organising a course
for SMEs on diffusion modelling and one on active
packaging.
European Indoor Air Monitoring and Exposure
Assessment Study (AIRMEX)-Public Buildings
In the frame of the AIRMEX project (Indoor Air Moni-
toring and Exposure Assessment Study) measuring
campaigns were carried out in Catania and Athens to
estimate indoor/outdoor relationships and personal
exposure concentrations for selected volatile organic
compounds (aromatics, carbonyls, terpenoids). The
measuring objects included public buildings (town
halls, guild halls), schools and kindergartens. Personal
exposure measurements were conducted with employ-
ers and/or teachers already working in the pre-
selected working environments. It was found that
generally the total VOC concentrations inside the
buildings are higher and/or similar to the outdoor
concentrations. In buildings located in the city centre
there is almost no difference between indoor and out-
door pollutant levels. Almost always the personal ex-
posure concentrations are higher than those indoors
and outdoors indicating the presence of unknown
sources for VOCs. The measuring campaigns will be
continued in 2004, including cities in other European
countries.
Toxicogenomics
Activities in the area of environmental toxicology in
the last five years evolved from support to EU Strategy
on Endocrine Disruptors and International co-opera-
tion, which produced the following milestones:
• WHO-IPCS Global Endocrine Disruptors Research In-
ventory (GEDRI), located at the JRC
• WHO-IPCS Global Assessment of Endocrine Disruptors
(GAED), final report, 2002
• EU/US Transatlantic Co-operation in Human and En-
vironmental Health on EDCs, Ispra April 2001
• Co-ordination of the research project EDAEP, Endo-
crine Disrupting Ability of Environmental Pollutants,
founded by DG Research, 1995-1999
• WHO-IPCS Report on Integrated Risk Assessment, 2002
The current main activities are focused on the develop-
ment of methodologies to assess health effects from
the exposure to chemicals and their mixtures (biomark-
ers of exposure and effects). Major problems in evaluat-
ing co-exposure of consumers to chemical mixtures
were presented at the ISEA 2003 Satellite “Workshop on
Cocktail Effects”, which was jointly organized by the
JRC and the EEA (European Environmental Agency). A
toxicogenomic approach was developed to identify ear-
ly markers of effects during development by long-term
exposure of low doses of laboratory animals to chemi-
cals and analyzing the gene expression in target organs
and tissues. These studies will be extended to co-
exposure to mixtures of chemicals at environmental
doses from foetal period to adult age. Gender difference
represents a major example of gene-environment inter-
actions, as it was demonstrated by our studies on the
semi-chronic exposure to arsenic in drinking water.
The relevance of individual gene patterns in modulating
the toxic responses following exposure to chemicals
was a major conclusion at the Workshop on “Gender Dif-
ference in Risk Assessment” jointly organized by the
JRC and SGOMSEC (exact name) in November 2003. The
use of DNA-macroarrays technologies for diagnostic
purposes was explored by analyzing the gene expres-
sion in a human kidney cancer specimen. A joint activ-
ity with the European Organization for the Research
and Treatment of Cancer has been initiated to charac-
terize the gene expression pattern in kidney cancer in
40 case study specimens from several European Coun-
tries.
The INDEX project
(Critical Appraisal of the Setting and
Implementation of Indoor Exposure Limits in the EU)
The main purpose of the project is to provide a priori-
tized list of indoor originated chemical pollutants that
could be regulated in the future. This list will be formed
based on the risk assessment, which will be done by
combining existing exposure data of the European pop-
ulations and the available toxicological doe/response
data. Finally, the project will provide suggestions and
recommendations on potential exposure limits for the
prioritized substances. In 2003 a list of indoor pollut-
ants, including benzene, formaldehyde, acetaldehyde,
CO and NO2 has been established, to be considered of
high priority for future regulatory actions. Risk assess-
ment reports for these compounds are partly prepared
and discussed. This work will continue and will be final-
ized by December of 2004.
Photo-catalytic Innovative Coverings Applications
for De-pollution Assessment (PICADA)
A European consortium of industrial enterprises, re-
search institutions and the JRC is running a test pro-
gramme for innovative construction materials set to
help in the fight against air pollution. The “smart” con-
struction materials (plaster, mortar, architectural con-
crete) and coatings are developed in the frame of the
PICADA project.
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The results of the studies undertaken (in the INDOOR-
TRON facility) lead to the conclusion that construction
materials and coatings containing titanium dioxide
(TiO2) play a significant role in the degradation of or-
ganic and inorganic air pollutants after illumination
with UV and/or solar radiation. After six hours of irradi-
ation it was calculated that up to 30% of NO2 and up to
90% of NO were photo-catalytically degraded. For NO2
more ad-/absorption phenomena were observed than
for NO. As far as the photo-catalytic velocity is con-
cerned, a value of 0.2 cm/sec was calculated for NO2
and 0.3 cm/sec for NO, after 1 hour of irradiation.
Preliminary Results on the Impact of Various Air
Exchange Rates on the Levels of Environmental
Tobacco Smoke (ETS) Components
In the frame of activities to evaluate human exposure
to ETS components in indoor environments, a series of
tests were undertaken in 2003 to investigate the im-
pact of various ventilation rates on the air concentra-
tion of ETS-components. The tests were carried out at
the European Commission-Joint Research Centre’s IN-
DOORTRON facility, a 30 m3 walk-in type environmental
chamber.
Preliminary evidence indicates that changes in ventila-
tion rates simulating conditions expected in many resi-
dential and commercial environments during smoking
do not have a significant influence on the air concen-
tration levels of ETS constituents, e.g. CO, NOx, aromatic
compounds, nicotine. This suggests that efforts to re-
duce ETS originated indoor air pollution through higher
ventilation rates in buildings, including residential are-
as and hospitality venues, would not lead to a mean-
ingful improvement of indoor air quality.
Moreover, the results show that “wind tunnel”-like rates
or other high rates of dilution ventilation would be ex-
pected to be required to achieve pollutant levels close
to ambient air limit values.
European Collaborative Action (ECA):
Urban Air, Indoor Environment and Human Exposure
In 2003, the European Collaborative Action on “Urban
Air, Indoor Environment and Human Exposure” issued
the Report No. 23 on “Ventilation, good Indoor Air
Quality and rational use of energy”.
The aim of this report is to provide information and ad-
vice to policy and decision makers, researchers, archi-
tects, designers, and manufacturers on strategies for
achieving a good balance between good indoor air
quality (IAQ) and the rational use of energy in build-
ings, available guidelines and assessment techniques
on energy and IAQ, significant trends for the future
with implications for IAQ and the use of energy in
buildings; and an indication of current research issues.
ACTION THEXAS PHYS
In the frame of a holistic approach to the total human
exposure concept, the health effect of physical stres-
sors, like UV radiation, noise and EMF on human well
being will be estimated and assessed as the basis for
the development and implementation of common meas-
urement methods and protocols — common exposure
models and exposure guidelines.
The work will be carried out in dedicated laboratories
specialised in the different types of exposure pathways
and stressors. These are being developed to act in their
The INDOORTRON with titanium dioxide coated construction material
The smoking machine installed inside the INDOORTRON
Clear sky, high UV surface albedo
respective areas as Reference Laboratories at EU level
to improve the currently achievable quality, representa-
tiveness and comparability of measured data related to
consumer and occupational exposure.
The following activities were carried out in 2003:
UV Radiation measurements of the European
Reference Centre for UV Radiation Measurements
(ECUV)
The PCE Unit hosts the European Reference Centre for
UV Radiation Measurements (ECUV, http://ecuv.jrc.it/).
The main task of ECUV is to support the quality assur-
ance of spectral solar UV measurements in Europe. It al-
so continuously monitors the solar UV radiation at the
JRC Ispra site. A mobile spectroradiometer system has
been developed and validated. The advantages of this
approach are that local monitoring instruments do not
need to be transported and are used in their natural en-
vironment during the intercomparison. Furthermore, a
site can be visited at regular intervals to check its sta-
bility over extended time periods. While this is a more
realistic evaluation of a monitoring site, it places strict
criteria on the performance and operation of the mobile
instrument that must be proven to be stable at a level
against which all other instruments will be judged. The
quality assurance of spectrally resolved ultraviolet irra-
diance measurements was performed at 14 UV monitor-
ing sites in Europe using a mobile spectroradiometer
system developed within the project QASUME (Quality
Assurance of Spectral Ultraviolet Measurements in Eu-
rope through the development of a transportable Unit)
The results obtained so far have confirmed the unique
potential offered by such a mobile unit for providing
on-site quality assurance of solar ultraviolet irradiance
measurements.
Satellite-derived UV climatology
and UV Human Exposure Modelling
The first version of a European satellite-derived UV ra-
diation climatology over Europe was completed in
2003. It covers the period from January 1984 to Octo-
ber 2003. It consists in maps of the surface dose rates
and daily doses, covering Europe (12E-32E, 34N-74N)
with a spatial resolution of 0.05 deg. The method basi-
cally consists in using a standard radiative transfer
code (UVspec) and in exploiting various sources of in-
formation to assign values to the influencing parame-
ters. GOME, TOMS or TOVS data are used for the total
column ozone. The maps are available for several action
spectra: UVA, UVB, erythemal, SCUPh (Skin Cancer),
DNA and PLANT. The data set documents the year-to-
year variability in the UV radiation during the 19 years
period, which varies according to the month and can
reach ±50% over large areas.
In a subsequent step these data are used for human ex-
posure modelling. The UV exposure of a person strongly
depends on behaviour (activity, clothing and protec-
tion measures, location in space and time). The differ-
ent parts of the body also receive very different doses,
depending in particular on the orientation of the skin
surface (e.g. the exposure of the face is closer to that
of a vertical surface, that of the shoulders to an hori-
zontal surface). So far, the UV climatology contains the
so called “downwelling irradiance”, which represents
the exposure of a horizontal surface. The intermediate
outputs of the climatology and the radiative transfer
models allow estimating the directional distribution of
the surface UV light (radiance) and hence the exposure
of an arbitrarily oriented surface. In this way, the po-
tential exposure can be computed for different parts of
the body. To approach the real exposure it will still be
necessary to take into account the other factors (activ-
ity, clothing, etc.).
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Scheme on different exposure situations
Cloudy sky, low UV surface albedo Clear sky, low UV surface albedo
50
European Information System
on Electromagnetic Fields (EIS-EMF)
The main objective of EIS-EMF, is to implement a EU-
wide programme on EMF risk communication, and con-
tribute to the development of a EU Official risk commu-
nication channel on EMF. The aim is to (1) provide
quality information and advice for the EC and MS ac-
tions and communication needs, and (2) promote com-
mon practices and standards for risk perception moni-
toring and risk communication at EU level, and ela-
borate tools for the dissemination of information to
stakeholders and EU citizens. In 2003 the development
of a Web-based information platform on public health
issues related to EMF has commenced. In addition, a fo-
rum for a systematic stakeholders dialogue between sci-
entists, industry, NGOs, and EU policy-makers, is cur-
rently being set up together with a FP6 EU-wide Scien-
tific Network (EMF-Net) to identify, analyze, validate
and disseminate information on emerging issues relat-
ed to human exposure to EMF.
Action 4315: BEVABS
For several years BEVABS has contributed to the devel-
opment of advanced analytical methods based on Nu-
clear Magnetic Resonance (NMR) and Isotopic Ratio
Mass Spectrometry. These methods have a broad poten-
tial of application for many aspects of European policy.
The institutional work for the EU Wine Isotopic Data-
bank is carried out in close collaboration with official
Member States laboratories (EC Reg 2729/2000). In
Comparison between Measurements and PROPLIN Model:
M1 vs M9 GradT=0, No Turbulence
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Formulation and implementation
of directives related to environmental noise
In 2003, the PCE Unit has established the Environmen-
tal Noise Monitoring Lab (ENML), which consists of
three mobile units for long-term noise and micro-
meteorological measurements. The ENML supports the
development and validation of harmonized noise com-
putational and measurement methods in the EU and is
involved in several projects with the aim to study per-
sonal exposure to environmental noise and associated
health effects, including research concerning the inter-
action among physical and chemical stressors and their
potential health effects.
In the context of the HARMONOISE project (“Harmo-
nised, Accurate and Reliable Methods for the EU Direc-
tive on the Assessment and Management of Environ-
mental Noise”) five measurement campaigns to collect
noise & micrometeorological data, needed for the
validation of the harmonised models under develop-
ment, were prepared and successfully performed in (7-
15 April 2003, La Crau (F), 30 June to 8 July, 2003, St.
Berthevin (F), 21-31 July 2003, Vada (I), 29 September
to 8 October 2003, St. Berthevin (F) and 20-31 October
2003, Vada(I)).
The analysis of the data measured in the first experi-
mental campaign of the HARMONOISE project showed
some typical behaviour of sound propagation and some
interesting results: at distances from the source higher
than 300 m, the attenuation of noise is almost the same
at all frequencies (unlike at shorter distances in which
the attenuation at high frequencies is normally higher
than the one at low frequencies), considering the char-
acteristics of the terrain, and for certain meteorological
conditions (absence of wind, etc). The comparison be-
tween the measurements and the predictions of the the-
oretical model showed generally good results, but the
model seems not to take into account the presence of a
hollow at 250-315 Hz (Fig. 1). The aforementioned dis-
crepancies show that results the of the HARMONOISE
Project will be very important to improve the perform-
ance of existing prediction models, taking into account
meteorological conditions, above all at long distances.
Under request of different noise stakeholders in the EU
the JRC-IHCP/PCE/ENML undertook the initiative to
standardise at European level the methodologies to
measure acoustic ground impedance, a parameter which
largely influences outdoor noise propagation. A techni-
cal meeting was organised to make a first comparison
among the different techniques (27-29 October 2003,
Vada (Tuscany).
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the past years, BEVABS has carried out the develop-
ment and validation of the method for the determina-
tion of the 13C/12C isotope ratio of ethanol, which has
been adopted at International level by the Office
International for Wine and Vine (OIV) and in March
2003 as official method by the European Union (EC Reg
440/ 2003). A workshop was organised in June 2003
with the specific objective of extending the network of
EU Wine Databank official laboratories to Candidate
Countries and to establish the state of the art of NMR
and isotopic techniques applied to anti-fraud in
Europe. BEVABS continued transferring know-how
through continuation of specific training of scientific
staff from Member states and accessing countries:
1expert from Portugal, 1 from Austria and 2 from Czech
Republic stayed in BEVABS laboratory for periods of 2
to 3 weeks for specific training on isotopic analysis of
wine and other goods. Three rounds of FIT-Proficiency
testing (Food analysis using Isotopic Techniques net-
work- Proficiency Testing) were organised in 2003 and
were used for monitoring the performance of isotopic
measurements within the network of laboratories of
the EU Wine Databank. Besides, very active research
has taken place through shared cost actions projects,
for development of new methods for detection of fraud,
control of authenticity and verification of the origin of
goods and agricultural products. The projects MEDEO
(NMR and isotopic techniques for detection of adulte-
ration of olive oil) and GLYCEROL (methods for detec-
tion of adulteration of wine by illicit addition of gly-
cerol) were completed in 2003 and the main results
will be communicated to interested bodies (DG AGRI,
International office for Wine and Vine and Internation-
al Oil Council). Three projects will be continued in the
next years: WINE-DB (extension of EU Wine Data bank
to several Candidate Countries and non EU countries),
SPREADS, (detection of adulteration of spreadable
fats), COFAWS (confirmation of the origin of farmed
and wild salmon).
A considerable part of the above projects are dedicated
to NMR profiling techniques and are now extended to
metabolite fingerprinting and identification of biomar-
kers in biological matrices (Metabonomics) in link with
the actions THEXAS-PHYS and THEXAS- CHEM. This ap-
proach is foreseen to be further developed in the next
years in relation to the Environment and Health and hu-
man exposure issues.
A scientific highlight of 2003 was the second Interna-
tional Symposium on Isotopomers (ISI 2003, Stresa on
4-6 November). The symposium was organized by IHCP
with the collaboration of IES and the support of Japan
Science and Technology Agency and of the Internation-
al Atomic Energy Agency. High level scientists from EU
Member Sates, Norway, US, India and Japan partici-
pated in ISI2003 for presentation of research works on
isotopomers ranging from Environmental studies to an-
alytical methods for food authenticity or for medical
diagnostics
(http://ihcp.jrc.cec.eu.int/EVENTS/ISI2003/
isi2003.html).
The NMR laboratory of BEVABS
PCE SELECTED PUBLICATIONS IN 2003
BAYO, M., M.A. SERRA and L. A. CLERICI. In Vitro detection of
neuronal stress induced by mercury componends in cerebellar
granule cells from hsp 70/hGH transgenic mice
BORDE, R. and J. VERDEBOUT, “Remote sensing of aerosols opti-
cal thickness over various sites using SeaWiFS or VEGETATION
and ground measurements”, Remote Sensing of Environment,
vol 86 issue 1, 30 June 2003, pp 42-51.
BRERETON, P.,  S. HASNIP, A. BERTRAND, R. WITTKOWSKI, C. GUI-
LLOU. “Analytical methods for the determination of spirit drinks
Trends”, Analytical Chemistry, Vol. 22, No. 1, 2003, pp 19-25.
BURGER, J., DÍAZ-BARRIGA, F., MARAFANTE, E., POUNDS J. and
ROBSON, M. “Methologies to examine the importance of host
factors in bioavailability of metals”. Ecotoxicology and Environ-
mental Safety, vol 56 (2003) 20-31.
CLAUSEN, G. E. DE OLIVEIRA FERNANDES, W. DE GIDS, C. DEL-
MOTTE, S. OLAF HANSSEN, S. KEPHALOPOULOS, MARIE-CLAUDE
LEMAIRE, T. LINDVALL, F. NICOL, M. SANTAMOURIS, O. SEP-
PANEN, C. J M VAN DEN BOGAARD, M. WILSON, P. WOUTERS. ECA
Report No. 23 on "Ventilation, Good Indoor Air Quality and Ra-
tional Use of Energy", EUR 20741 EN, 2003
FANTONI, L., C. SIMONEAU.  “European survey on the contamina-
tion of homogenised baby food by epoxidised soybean oil from
plasticised PVC gaskets”. Food additives and Contaminants (in print)
GEISS, O., D. KOTZIAS. “Determination of Ammonium, Urea and
Chlorinated Pesticides in Cigarette Tobacco”. Fresenius Env. Bul-
letin (2003), Vol. 12, No. 12, pp 1562-1565.
GRÖBNER J., “Improved entrance optic for global irradiance
measurements with a Brewer spectrophotometer”, Applied Op-
tics, 42, 2003.
GUILLOU, C. et al. “Analytical Methods for the Determination of
spirit drinks”. Trends in Analytical Chemistry, Vol.22, No. 1, 2003
MEERKÖTTER, R., VERDEBOUT, J., BUGLIARO, L. EDVARDSEN, K.
and HANSEN, G. “An evaluation of cloud affected UV radiation
from polar orbiting and geostationary satellites at high
latitudes”. Geophys. Res. Lett., 30, ASC 8-1  8-4.
NERIN, C., J. ALBINANA, MR PHILO, L. CASTLE, B. RAFFAEL, and
C. SIMONEAU. “Evaluation of some screening methods for the
analysis of contaminants in recycled polyethylene terephtha-
late flakes”. Food Additives and Contaminants, July 2003, vol.
20 (7): 668-677
PAINI, D. B. GAUVREAU, M. BERENGIER, S. KEPHALOPOULOS, G.
LICITRA, A. IACOPONI, S. CIESLIK, D. KUEHNER, “HARMONOISE-
first experimental road traffic noise campaign: comparison be-
tween meteorological and acoustical measurements and exist-
ing noise prediction models”, Proceedings of the 5th European
Conference on Noise Control (EURONOISE2003), 19-21 May
2003, Naples (Italy), pp. 518-IP, 1-6, ISBN 88-88942-00-9.
REMBGES, D.,  KOTZIAS, D. “Monitoring TSP, PM 10 and PM 2,5
at a semi-remote area in Northern Italy”. Fresenius Environmen-
tal Bulletin, 2003, Vol. 12, No 5, 402-405.J8
RENIERO, F., C. GUILLOU, C. FRASSINETTI, S. GHELLI (2003).
“DISCO-a general computer program for the computation of acid
dissociation constants of polyprotic molecules in water and bio-
logical fluids, from nuclear magnetic resonance data: applica-
tion to polyamines”. Analytical Biochemistry, 319, pp. 179-194.
RENIERO, F., C.GUILLOU, L.CALABI, L.PALEARI, L.BIONDI, M.DE
MIRANDA, S.GHELLI (2003). “Determination of dissociation
constants of (4RS)-[4-carboxy-5,8,11-tris(carboxymethyl)-1-
phenyl-2-oxa-5,8,11-triazatridecan-13-oic acid] in water and
biological fluids by means of nuclear magnetic resonance spec-
troscopy and the DISCO software package”. Analytical Biochem-
istry, 319, pp. 195-205.
SCOTTO DI MARCO, G., S. KEPHALOPOULOS, M. JANTUNEN, J.
RUUSKANEN, “The main determinants and estimation of popu-
lation exposure to carbon monixide in the city of Helsinki,
Finland”, Proceedings of the 4th International Conference on Ur-
ban Air Quality: Measurement, Modelling and Management, 25-
27 March 2003, Charles University, Prague, Czech Republic, pp.
367-370, R.S. Sokhi and J. Brechler (Editors), ISBN,
0750309547
WUTTKE S., VERDEBOUT J. and SECKMEYER G., “An improved al-
gorithm for satellite-derived UV radiation”, Photochemistry and
Photobiology, Vol 7, Iss 1, January 2003.
CONTACTS
Head of Unit
Dimitrios Kotzias
Tel.: +39 0332 789952
Fax: +39 0332 789453
Dimitrios.kotzias@jrc.it
Exposure Measurements and Risks of Chemicals
Demosthenes Papamelethiou / Dimitrios Kotzias
Tel.: +39 0332 789952
Fax: +39 0332 789453
Demosthenes.Papamelethiou@jrc.it
Exposure Modelling and Environmental Noise
Stylianos Kephalopoulos
Tel.: +39 0332 789871
Fax: +39 0332 785867
Stylianos.kephalopoulos@jrc.it
UV Laboratory / ECUV
Diana Rembges / Julian Groebner
Tel.: +39 0332 785953
Fax: +39 0332 785924
Diana.rembges@jrc.it
Toxicogenomics
Erminio Marafante / Libero Clerici
Tel:+39 0332 789144
Fax:+39 0332 786292
Erminio.marafante@jrc.it
BEVABS
Claude Guillou / Fabiano Reniero
Tel.: +39 0332 785678
Fax: +39 0332 789303
Claude.guillou@jrc.it
Contact Materials
Catherine Simoneau / Paola Piccinini
Tel.: +39 0332 785889
Fax: +39 0332 785707
Catherine.simoneau@jrc.it
52
Institutional Actions
Nanobiotechnology for Health Applications (NBT)
Competitive Projects
STERIPLAS, BIOGRAD, IFCA, LAPLADIS, MEDPHOT,
EVIGeM, SPOTS, “COMO”, PLASMATECH
Web information resources
http://ihcp.jrc.it
http://bms.jrc.it
http://ihcp.jrc.cec.eu.int
bms
Biomedical Materials
and Systems
In the last five years, the BMS-Unit has developed as a
horizontal “enabling” technology provider in support of
the JRC priority areas for policy related research. The
Unit’s strength lies in the cross-functional research ac-
tivities, which are performed in the frame of two insti-
tutional Actions on ‘Nanobiotechnology for Health Ap-
plications’ (NBT) and ‘Medical Devices and Health
Technology’ (MEDTECH), which were initiated in FP6.
NANO-BIOTECHNOLOGY FOR HEALTH APPLICATIONS
At the convergence of physics, chemistry and biology,
Nanobiotechnology deals with the understanding and
transformation of biosystems (living or non-living) to
create and use functional structures, devices and sys-
tems, which have novel properties and functions that are
associated with their small and/or intermediate size.
This allows, for instance, to study biological systems at a
scale not attained before, to modify interfaces in order
to improve their compatibility with biological entities,
and to create new probes or sensors with unique, size-
specific properties on the atomic or molecular length
scale. These new opportunities are of major importance
for the development of high throughput screening sys-
tems for toxicology applications as well as for chip tech-
nologies. Miniaturisation down to the nanometer scale
will be one of the great challenges within the next years.
The NanoBiotech IHCP institutional project aims at
building a technology platform based on long range ex-
perience in surface engineering and opto-electronic de-
vices that will allow us to develop new bio-interfaces, bi-
osensors and diagnostics systems with applications in
the emerging Environment and Health priority. Applica-
tions in the field of chemicals toxicology testing and
chemical exposure are evaluated through the collabora-
tion with other Units of the JRC (ECVAM and PCE). The
objective to integrate the Nanobiotech project into the
European Research Area (ERA) has been particularly suc-
cessful with our participation in the Network of Excel-
lence Nano2Life. This is the first European network on
Nanobiotechnology where IHCP-BMS has a central role in
defining the joint research programme of the Network.
A biosensor is generally defined as a compact analytical
device incorporating a biological or biologically derived
sensing element either integrated within or intimately
associated with a physicochemical transducer. A bio-
sensor produces either discrete or continuous signals,
which are proportional to the concentration of a single
analyte or a related group of analytes. The interaction
between the analyte and recognition biomolecules is an
event on the molecular scale, which can be detected as
a local change in mass, in optical or electrical proper-
ties. Recognizing elements are generally biomolecules
such as enzymes, antibodies or even cells with highly
specific recognition abilities, which are usually immo-
bilized on solid supports. Such transducers can be de-
vices such as piezoelectric materials, electrodes or
wave-guides that are based on the analyte-biomolecule
interaction and yield a measurable electric or optical
signal of their corresponding response.
The NBT activities are focused on two essential subjects
of research, the biological/non biological interfaces as
well as related end point detection methods.
Interfaces
The interaction between the organic recognition bio-
molecule and inorganic transducer surface is a key as-
pect in the development of a biosensor, since it has a
direct consequence on the sensitivity and the specifici-
ty of sensing. In order to guarantee high sensing per-
formance, engineered surfaces must be developed for
the immobilisation of the recognition biomolecules
that can interact specifically with the target molecules
such as proteins, enzymes or antibodies. In particular,
new surface coatings must be assessed with regard to
their physical and chemical stability and their protein
adsorption capacity.
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Classical biosensor architecture
Patterning of these surfaces at the sub micron level is
an additional essential step to match the sensor per-
formance to the requirements and to develop miniatur-
ized sensitive, fast, portable and multi analysis sensors.
The physical and chemical properties as well as the
microstructure of the functionalised surfaces, interfac-
es and layers are characterised with advanced tech-
niques as Atomic / Chemical Force Microscopy (AFM/
CFM), X-ray Photon-Electron Spectroscopy (XPS), Time-
of-flight Secondary Mass Spectroscopy (ToF-SIMS),
Scanning Electron Microscopy (SEM), Quartz-Crystal-
Microbalance with Dissipation Analysis (QCM-D), etc.
Surface functionalisation
The activities in 2003 were concentrated on the synthe-
sis of surfaces with different physical and chemical
functionalities for triggering the interactions between
the bio-molecules and the transducer materials. Poly-
meric films with different properties i.e. protein ad-
sorbing (fouling) and protein resistant (anti-fouling)
were synthesised via Plasma Enhanced Chemical Vapour
Deposition (PE-CVD). Functional surfaces with -NH2 or
–COOH functional groups promoting controlled protein
adsorption have been produced by poly allylamine
(pAL) and poly acrylic acid (pAA) film deposition, re-
spectively. Protein resistant films have been developed
by deposition of poly-ethylene glycol (PEG)-like films.
The efficiency of the developed layers with regard to
protein adsorption has been verified with QCM-D. This
technique allows studying the formation of thin films
such as proteins, polymers and cells on surfaces in a
liquid by measuring both the dissipation and the reso-
nance frequency of a quartz crystal. The stability of
pAA- and PEG like films upon addition of phosphate
buffered solution (PBS) has been verified. A high level
of Bovine Serum Albumin (BSA) adsorption on pAA
films (0.3 µg/cm2) has been observed as compared to
anti-fouling film (PEG).
Another important category of materials in the area of
biochemical sensors are those based on electrochemi-
cally grown conductive organic polymers such as
polypyrrole (PP) and polyaniline. The usefulness of
these materials derives from the relative simplicity by
which they may be deposited together with enzymes or
antibodies such that the active biomolecules become
physically trapped or immobilized in a conductive ma-
trix without suffering excessive denaturing. This con-
ductive matrix with a biochemically active component
may then be used as transducer in sensors based on
electrochemical or impedometric detection methods.
The preliminary studies conducted in this area have con-
centrated on the development of porous silicon as a
high surface area substrate for deposition of galvanos-
tatically deposited polypyrrole (PP). Conditions have
been determined which produce stable uniform relative-
ly smooth polymer films, which have been characteriza-
tion using surface analytical techniques such as XPS and
TOF-SIMS. Detailed surface mass spectrometry studies of
PP and deuterium substituted PP have been undertaken
and will provide the basis for future detailed studies of
the polymer system when biomolecular species will be
incorporated in the conductive film matrix.
Functionalised surface nano-patterning
For improving the sensor sensitivity, e.g. to decrease
harmful background signals, nanostructured surfaces
are produced for local control of the protein adsorption.
Using nanosphere lithography, nano-domes with COOH
functionalities distributed on a substrate having anti-
fouling properties were produced generating a chemical
contrast on a single surface at the sub-micron level.
The process has been carried out combining plasma
deposition and etching techniques with colloidal parti-
cles masking. The picture below shows an example
where polymeric nano-domes of about 50 nm width
have been created at the top with bio-specific chemical
functionalities.
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of the nano-structured surface
Surface - Protein interaction
Protein adsorption experiments using Bovine Serum Al-
bumin (BSA) as a model protein, were performed on the
‘nano-dome’ surfaces. A Field Emission-Scanning Elec-
tron Microscope (FESEM) was used for the topographic
characterisation of the adsorbed proteins. The results
evidence how the small BSA clusters (10-30 nm) are se-
lectively bonded to the functional plateau of the pAA-
domes. In particular they arrange themselves in the
centre of the plateaus and on the edges where the sur-
face free-energy is very high. No BSA was found in the
surrounding matrix. With this method, a controlled or-
ganisation of protein films can be obtained.
END POINT DETECTION
The development of biosensors with potential applica-
tions in the field of chemical exposure is another objec-
tive of the Nanobiotech project. Chemical exposure bio-
sensors are produced using the Quartz Crystal Micro-
balance technique and the Surface Plasma Resonance
(SPR) method.
Sensors based on antibody-antigen interactions
In 2003 a biosensor has been developed, which is based
on antibody-antigen interactions to detect a particular
environmental or food contaminant. The covalent anti-
body binding on the quartz crystal gold surface is
achieved on amine functionalised surface through the
deposition of a Self-Assembled Monolayer (SAMs) using
4-aminothiophenol. The antibody binding is performed
using glutaraldehyde for cross-linking and protein A for
better antibody orientation. SAM or polymer formation
stability studies in phosphate buffer solution (PBS) are
performed using QCM-D. After the optimisation of each
step, antibody-antigen interactions will be monitored
using the QCM-D for detecting Ab-Ag binding.
Fluorescence Techniques
The Nanobiotech project is also providing direct scien-
tific and technical support to the ECVAM Unit in the area
of endpoint detection. End point measurement is a key
step in the toxicology testing of chemical substances
using in vitro cell-based assays. Responding to the sig-
nificant demand for more rapid and more sophisticated
test methods, with the adoption of the new EU chemi-
cals legislation, the Nanobiotech project aims to assist
ECVAM in applying advanced optical measurement tech-
niques to improve the efficiency, reliability and specifi-
city of regulatory toxicity tests which use cells and en-
gineered tissues in culture.
Among the techniques being investigated, fluorescence
based methods are of particular interest. However, un-
like traditional fluorescence labelling approaches that
rely on the addition of a fluorescence stain or dye, our
methods are primarily based on identifying and measur-
ing the concentration of endogenous fluorophores,
which are already present in the cell or medium. Al-
though it is more technically challenging to detect the
very low levels of fluorescence light emitted by small
concentrations of endogenous fluorophores (also known
as auto-fluorescence), it allows a completely non-des-
tructive analysis of an assay and eliminates many chem-
ical processing steps associated with endpoint detec-
tion that are often time consuming and prone to opera-
tor error. One innovative feature of the auto-fluor-
escence imaging system being developed for ECVAM is
the inclusion of an acousto-optic tuneable filter (AOTF).
This device, when mounted on a viewing port of a fluo-
rescence microscope, offers an exceptional extinction
ratio resulting in almost complete elimination of back-
ground noise. The ultra-high signal-to-noise perform-
ance, coupled with the possibility of randomly accessing
an infinite amount of different filtering wavelength
bands, has led to the development of a powerful fluores-
cence imaging spectrometer capable of detecting and
mapping fluorescent biomolecules. In parallel with the
construction and optimisation of the detection system,
work is underway in identifying candidate endogenous
fluorophores which concentration is directly linked to a
toxicological endpoint. For example, acute toxicology
assays often aim to assess cell viability through an end-
point measurement that indicates the level of mito-
chondrial activity. NAD(P)H is an endogenous fluores-
cent molecule that is inherently involved in the
metabolic process in cells and thus if monitored, can re-
port on the viability of the cell without the addition of
exogenous substances.
Another fluorescence technique being applied to in vit-
ro toxicology testing is fluorescence lifetime measure-
ment (FLM). Rather than considering only the spectral
characteristics of fluorescent molecules, this method
actually measures the decay time or lifetime of fluores-
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cence emission stimulated by a very short pulse of exci-
tation light. In our set-up we employ a picosecond
pulsed violet laser diode (405nm) to excite the sample
and a Time Correlated Single Photon Counting system to
detect the time of arrival of each emitted fluorescence
photon. With suitable digital signal processing of the
acquired data a specific decay time can be calculated for
a particular fluorescent wavelength. Since different
fluorophores that emit at the same wavelength can be
distinguished by their decay times, this method offers
the possibility of detecting particular fluorescent bio-
molecules in the presence of significant auto-
fluorescence background generated by other fluorescent
biomolecules. Current efforts are focusing on integra-
tion of the FLM system on a fluorescence microscope to
allow fluorescence lifetime imaging (FLIM) of cell-based
toxicology assays.
Cyclotron Applications
In 2003, the general overhauling of the cyclotron was
concluded. The scientific activities were concentrated
on production technologies for medical radioisotopes
and materials research. Special emphasis was given to
training activities of young researchers including exter-
nal funding through the Marie-Curie Programme (Joint
ECVAM-BMS MC-Training Site, individual MC fellow-
ships).
MEDICAL RADIOISOTOPES
Fluorine-18 production
On December 19th, 2003 a contract has been signed be-
tween Amersham Health (now: General Electric (GE)
Healthcare) and the JRC Institute for Health and Con-
sumer Protection to begin at the Ispra Cyclotron the
commercial production for radiotracers for cancer diag-
nosis. The collaboration started in October 2001 with
the scope to establish at the Ispra Cyclotron a radio-
pharmaceutical production site for short-lived fluorine-
18 (18F) labelled radiotracers for Positron Emission To-
mography (PET). This resulted in the set-up of a pro-
duction according to the latest standards Good Manu-
facturing Practice (GMP) and Good Laboratory Practice
(GLP) as well as with licensing procedures for short-
lived radiopharmaceuticals.
The Ispra Cyclotron hosts the first production facility in
Italy with the license to sell 18F-FDG (18F-Fluo-
DeoxyGlucose) on the market. Up to now the wide use
of this technology was hampered by the high invest-
ments required to establish a cyclotron centre together
with a PET facility. The example will trigger more such
licensing procedures all over Italy and improve the ac-
cess of patients to PET diagnostics while making more
economic use of cyclotron capacity. This will improve
appreciably the access of cancer patients in Italy to
Positron Emission Tomography.
Radioisotopes for Therapy
Radiolabelled tumour seeking molecules have received
increased attention in the last decade, since they offer
significant advantages over traditional therapy ap-
proaches:
• Radiation doses for killing tumour cells can be deliv-
ered with tiny chemical quantities avoiding the side
effects of chemotherapy.
• The particle radiation can kill also tumour cells with
no immediate up-take of radiopharmaceuticals. This
“cross fire effect” is a major advantage over genetic
approaches to cure cancer.
• The variety of radioisotopes allows adjusting dose
rate and the striking distance of the “isotope cock-
tail” to the volume of the cancer to be treated.
• With the proper carrier molecules and a good match-
ing biological and physical half-life of the radio-
pharmaceutical this internal radiotherapy allows the
treatment of already disseminated cancers.
For these reasons the IHCP participates in research ef-
forts to make available the most promising cyclotron
produced radioisotopes like alpha-emitters (e.g.,
211At) and beta-emitters (e.g., 64Cu). These activities
have to be pursued with increasing intensity since the
number of cyclotron facilities capable of producing
nearly every desired radioisotope is shrinking within in
the EU. The IHCP follows these activities in close col-
laboration with external partners that guide the efforts
towards most promising radioisotopes. The IHCP efforts
are now co-ordinated with those of JRC-ITU, which has
a strong involvement in alpha immunotherapy trials,
both clinical and pre-clinical.
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18F-FluoDeoxyGlucose
Support to Technological Development
in Radiotherapy
The cyclotron is also supporting new approaches in ra-
diotherapy using particle beams. This new field of
hadron therapy (in Europe developed mainly at the GSI
Darmstadt in Germany), uses ions like protons, alpha
particles, carbon ions or even heavier particles. By ad-
justing the energy of the ion beam the depth of the
main energy deposition can be adjusted to the require-
ments of tumour irradiation with low radiation deliv-
ered to healthy tissue.
In collaboration with the TERA (TErapia con Radiazio-
ni Adroniche, Therapy with Hadronic Radiations) Foun-
dation support is given to the development of hadron
therapy by providing particle beams for the testing and
development of equipment to monitor the beam inten-
sity profile online during irradiation. Such equipment is
essential for treatment planning, medical quality con-
trol and patient safety.
BIOMEDICAL MATERIALS - TRAINING ACTIVITIES
Between 10% and 30% of the patients, who have re-
ceived a joint prosthesis relying on a metal-poly-
ethylene (UHMWPE) articulation, require a revision sur-
gery already after approximately 10 years due to aseptic
loosening of the implant. There is strong evidence that
this loosening is caused by the accumulation of submi-
cron sized wear debris in the periprosthetic tissue.
Thus, the main goal of research in improving the dura-
bility of orthopaedic implants is to reduce the number
of wear debris released from the implants.
The IHCP Orthopaedics Implant Testing Laboratory has
focused its activities in 2003 on wear and release test
methodologies using nuclear techniques. In this way
the added value of the IHCP cyclotron to these activi-
ties could be increased. Together with ECVAM the BMS
Unit hosts the Marie Curie Training Site BIORAD which
provides training to doctoral fellows on toxicity test
methods for biomaterials, particularly metal toxicity.
In the frame of the FP5 Shared Cost Action “BIOGRAD”
screening wear tests a new methodology for screening
wear tests of ceramic-ceramic wear couples based on
the ASTM 732 Reciprocating-Pin-Flat Test has been suc-
cessfully demonstrated.
Clinical and experimental studies indicate that modular
hip joint prosthesis, artificial knee joints and spinal fix-
ators are prone to fretting corrosion damage indicating
a clear need for research. An exploratory research
project, supported through an individual Marie Curie
Fellowship, has initiated in 2002, with the aim to de-
velop a quantitative and precise methodology for fret-
ting corrosion studies by combining radiotracer tech-
niques with mechanical testing. It has been de-
monstrated that material releases in the order of µg can
be detected, which is beyond the resolution of gravi-
metric methods. By element-specific charged particle
activation the release of certain ion species can be
monitored online during fretting fatigue in liquid me-
dia. First studies have been conducted in 2003 to simu-
late the ion release from the spherical head and the
stem.
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In January 2000 the European Commission proposed
the creation of a European Research Area (COM (2000)
6). The main objective was to enhance the efficiency and
innovative impact of Europe’s research effort through
better integration and co-ordination of research activ-
ities at a European level.
The IHCP has contributed to the implementation of a
European Research Area (ERA) through scientific net-
working, the promotion of research training and mobil-
ity, and support to EU enlargement.
NETWORKS
The IHCP sought to network with EU Member States, Ac-
cession Countries, and Association countries with a
view of co-ordinating research and exchange scientific
and technical information:
• European Network of GMO Laboratories (ENGL)
• European thematic network on Optical Methods for Med-
ical Diagnosis and Monitoring of Diseases (MEDPHOT)
• European thematic network on Innovative Plasma
Technology for Societal Needs (PLASMATECH).
ECVAM collaborates in 15 Networks in the form of Task
Forces on Acute fish toxicity, Biocompatibility testing,
Blood-brain barrier, Carcinogenicity, Endocrine Dis-
rupters, Good Cell Culture Practice, High-throughput
screening, Metabolism, Neurotoxicity, Pyrogenicity,
(Q)SARs, Sensitisation, Shellfish toxin testing, Skin Ir-
ritation and Toxicogenomics. Moreover, 1 Steering
Group on Biologicals was established with 6 members
from 6 countries. In total, 99 members from 14 coun-
tries (distribution: 35% Italy; 16% UK; 13% Germany;
11% France; 8% The Netherlands; 13% Others) are col-
laborating and disseminating information on tightly
defined tasks.
FACILITIES
The IHCP has a combination of facilities that have to be
set up at the EU level. Some of these facilities are:
Biocyclotron
The Biocyclotron is a highly versatile particle accelera-
tor with a rather large energy range and the capability
of accelerating protons and alpha particles (up to ener-
gies of 40MeV) as well as deuterons (up to 20MeV).
With this facility a wide variety of radioisotopes can be
produced, making it especially suitable for research
purposes.
Indoortron
The Indoortron laboratory is a unique, 30m3 volume
walk-in environmental chamber featuring controlled
temperature, relative humidity, air quality, and air ex-
change rate.
BEVABS
BEVABS has a specialized laboratory that aims to ensure
correct implementation of EU wine quality legislation.
RESEARCH TRAINING AND MOBILITY
The ERA promotes greater training and mobility of
young and senior researchers as they play an important
role in the collaboration and networking of European
research. Within this context, the IHCP hosted 55 col-
laborative staff including trainees, grant-holders (post-
graduate and post-doc), visiting scientists, and sec-
onded national experts.
SUPPORT TO EU ENLARGEMENT
The IHCP supports the adoption and implementation of
EU legislation (acquis communautaire) in the Accession
Countries through specialised enlargement activities
(training and workshops):
• ECVAM organised a practical training course on in vit-
ro methods for pyrogenicity testing in Hungary and a
workshop on alternatives to the use of animals in
higher education in Poland.
• Two PhD students from Candidate Countries are cur-
rently working at ECVAM on the development of
structure-activity relationships for pharmacotoxico-
logical endpoints and on the development of in vitro
testing methods for assessment of neurotoxic and
neurodegenerative potential.
• A scientist from Poland worked at ECVAM for a period
of six months in the key areas Systemic Toxicity and
Strategic Developments.
• During 2003, the JRC continued to host a doctoral
fellow from Bulgaria, to carry out a PhD on the QSAR
modelling of regulatory endpoints, in collaboration
with Liverpool John Moores University (UK).
• In support to the EU enlargement, a IUCLID course
was given in October 2003 in Bratislava (Slovakia).
The course was highly appreciated by the partici-
pants from the competent authorities in the new
Member States. More courses are scheduled in 2004.
In order to facilitate the correct use of IUCLID 4.0,
Guidance Documents are being drafted in the frame
of a joint collaboration with CEFIC.
Contributing to the European Research Area
Prizes/Awards
• Thomas Hartung was granted a honorary professor-
ship at the University Konstanz, Germany and the
Award for Environment and Society by LBS Baden-
Württemberg, Germany.
Nominations
• The US Environmental Protection Agency (EPA) has
nominated Andrew Worth as an expert consultant in
a newly-established Panel of the EPA Scientific Advi-
sory Board on Computational Toxicology.
Patents (received by IHCP)
• EP patent application on “Functionalization of intra-
coronary stents” (EP n° 02292525.9)
Training
• International training courses: analysis of food
samples for the presence of GMOs. The activity
started in the year 2000 as part of the collaboration
between JRC and WHO to promote food safety related
issues in WHO European Region, inside and beyond
current EU borders, with special consideration for Ac-
cession Countries, as well as Central and Eastern
Countries with transitional economies. The experi-
ence was very positive followed by intense contacts
with the participants, who frequently requested our
advice for the implementation and/or optimisation
of laboratories devoted to the analyses for GMO de-
tection. A second series of three Training Courses
was organized in the years 2002-2003, with exten-
sive participation of candidates from Accession
Countries.
To enlarge and enhance the benefits of training and
to support local training initiatives, the B&GMO Unit
explored the possibility to act as Training Centre for
trainees. For this purpose, one scientist from the Ag-
ricultural Biotechnology Centre (Environmental Bi-
osafety Research Institute - Gödöllõ, Hungary) was
hosted for 2 months in the B&GMO facilities.  As a
successful follow up of this initiative a Training
Course, specifically directed to Accession Counties,
took place in Gödöllõ, in November 2003.
Additionally, a training manual as a permanent sour-
ce of information describing all the techniques cur-
rently used for the detection and quantification of
GMOs was produced, edited and published in 2003
(http://gmotraining.jrc.it/). The manual covers a
wide variety of techniques for GMO detection, identi-
fication, characterisation, and quantification, in-
cluding theoretical information crucial for anyone
wishing to enter the field of GMO detection. The
manual, which is the first one published on this top-
ic, is currently being translated into Turkish and Rus-
sian for further publication.
• In 2003 the ECB organized 2 training courses regard-
ing IUCLID and the EU risk assessment procedures
and 3 IUCLID courses were successfully given to au-
thorities of the member states, candidate countries
and industry within ECB’s activities on biocides.
• BEVABS provides training for new users of isotopic
techniques, organises proficiency testing, communi-
cates technical recommendations and supports ac-
cession countries in joining the operational network
of EU wine databank anti-fraud laboratories.
• The BIORAD Marie Curie Training Site (ECVAM and
BMS Biocylotron laboratories) aims at high-level
interdisciplinary doctoral training on biomaterials
testing using radiotracers.
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E-training tools within the JRC enlargement action
on GMO detection
In order to reinforce Enlargement Action and respond
to the continuously increasing need of training beyond
the available training capacity, a new strategy based on
the use of multimedia tools for training was proposed
and introduced. The aim is to increase efficiency, pro-
ductivity and availability of training efforts by comple-
menting traditional training courses with new tools,
such as interactive DVD training. This activity is still
ongoing and the release is expected in 2004.
Finally, during 2003 three DNE/VS from Romania, Czech
Republic, and Poland were hosted and trained for a to-
tal period of 10 months. During this period, specific in-
dividual work programmes were followed to respond to
individual specific needs in the field of GMO detection,
and to allow direct participation in ongoing research
activities.
62
Competitive Activities (2003)–Examples*
* Shared-cost actions: participation in shared-cost activities with other successful consortia.
GM-FOOD & FEED
Aim:
Aim: Proposal for complementing the envisaged ac-
tion in the JRC work programme on GMOs to conduct
further work on post-market monitoring of GM food
and feed, to develop further guidance on detection
and sampling of GM food and feed, to provide scientif-
ic support to the Commission’s participation in inter-
national negotiations, notably in Codex Alimentarius,
and to organise a stakeholders’ conference (forum) on
GMOs in 2003.
B&GMOs
ECB
ECICS
Aim:
The purpose of this work is to carry out a study to as-
sess the feasibility of updating ECICS. This work will
be used to support DG TAXUD plans  for updating and
improving ECICS over the next two years.
ICAROS NET
Aim:
The objective of ICAROS NET is the development and
implementation of a networked interactive computa-
tional environment that allows the minimisation of
uncertainty in decision-making regarding operational
air pollution control and abatement in the urban en-
vironment and enhances the coherence in trans-
boundary environmental monitoring.
Partners:
• University of the Aegean (GR); Fraunhofer Gesells-
chaft Zur Foerderung der Angewandten Forschung
E.V., Mcmaster University (CAN); National Observa-
tory of Athens (GR); National and Kapodistrian Uni-
versity of Athens (GR); Space Imaging Europe SA
(SIE) (GR); KFKI Research Institute for Particle and
Nuclear Physics, Computer Network Centre, Labora-
tory of Speech Technology for Rehabilitation (KFKL)
(HU); Konkoly Thege M UT 29-33 (HU); National
Centre of Public Health (HU); Telespazio S.P.A.
(TPZ) (I).
OMNITOX
Aim:
The main activity is to conduct a feasibility study on
the potential for applying (elements of) Life Cycle As-
sessment (LCA) in chemicals policy.
Partners:
• Chalmers University of Technology AB (S); AB Volvo
Technological Development (VOLTD) (S); Procter &
Gamble Eurocor NV (PGEUR) (B); Stora Enso Oyj
(FIN); Antonio Puig SA (E); Randa Group SA (E);
Danmarks Tekniske Universitet (DK); Universiteit
Leiden (NL); Universitaet Stuttgart (D); École Poly-
technique Fédérale de Lausanne (CH)
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HARMONOISE
Aim:
To develop methods by which the sound power out-
put and the directivity of sources of road and rail
traffic can be described and assessed as an accurate
physical quantity which is independent of short dis-
tance sound propagation, including establishment of
a correlation with future legislation on limiting the
noise generation, set up of data base.
Partners:
• AEA Technology Rail BV (SP); Swedish National
Testing and Research Institute; Transport Research
Laboratory (UK); VTI, Swedish Road and Transport
Research Institute; Technical University of Gdansk,
Autostrade (I); TNO Institute of Applied Physics
(NL) (non-exhaustive list)
COFAWS
Aim:
Confirmation of the origin of farmed and wild salmon
and other fish.
Partners:
• Eurofins (F); Université de Nantes (F); North Atlan-
tic Fisheries College (UK); SINTEF Fisheries and
Aquaculture (SINTEFA) (NOR)
PCE
WINE DB
Aim:
Establishing a wine data bank for analytical parame-
ters for wines from third countries.
Partners:
• Bundesinstitut für gensundheitlichen Verbraucher-
schutz und Veterinärmedizin (D); Department for
Environment, Food and Rural Affairs (UK); Eurofins
(F); Vrije Universiteit (B); Ministry of Finance (CZ);
Agronomical University and of Veterinary Medicine
‘Ion Ionescu de la Brad’ (RO); National Institute for
Wine Qualification (HU); Croatian Institute of Viti-
culture and Enology (CR)
EIS-CHEMRISKS
Aim:
The key objective of this project is to develop EIS-
CHEMRISKS as a European-wide expert network ani-
mated and operated by the JRC to systematically ex-
change and assess information on emerging issues
related to “Risks from chemicals released from cus-
tomer products / articles”.
MEDEO
Aim:
To develop methods based on NMR and isotopic tech-
niques and tested for detection of adulteration of ol-
ive oil.
Partners:
• Instituto de la Grasa (CSIC) - Sevilla (E); Eurofins An-
alytics - Nantes (F); Central Science Laboratory- York
(UK); CNR - Roma (I); Istituto Elaiotecnica Pescara
(I); Stazione Sperimentale degli Oli e Grassi (SSOG)-
Milano (I); National Hellenic Research - Athens (GR)
CHEM-TEST
Aim:
To develop, in addition to EIS-CHEMRISKS, a tool that
supports the General Product Safety Directive and the
relevant parts of REACH, by developing missing expo-
sure data and chemical methods from products and
articles.
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FOODMIGROSURE
Aim:
To develop physico-chemical migration models of mi-
gration processes from plastics to real foodstuffs as a
tool for estimation of consumer exposure from food
contact materials.
Partners:
• Fraunhofer Institute of Process Engineering and
Packaging, Freising (D); Central Science Laboratory,
Dep. Food Environment & Rural Affairs, York (UK);
FABES Forschungs GmbH für Analytik und Bewer-
tung von Stoffübergängen (D); Pira International,
Leatherhead (UK); University Santiago de Compos-
tela, Dpto. Química Analítica, Nutrición y Broma-
tología of the Facultad de Farmacia (ES); Vienna
University of Technology, Inst. Food Chemistry and
Food Technology (A); Nestlé Research Center,
Lausanne (CH); European Chemical Council; Bu-
reaux International aux Techniques (BE)
EIS-EMF
Aim:
To set up a European Information System on public
health protection issues related to Electromagnetic
fields (EIS-EMF) as a common basis for decision mak-
ers to increase the coherence of the approaches taken
in the various Member States and help restore public
confidence.
Partner:
• Research Centre Seibersdorf (A)
GC-IRMS
Aim:
Feasibility study for establishment of reference mate-
rials for the gas chromatography isotopic ratio mass
spectrometry.
Partners:
• Eurofins Analytics - Nantes (F); Central Science Lab-
oratory - York (UK); INETI - Lisboa (P)
SPREADS
Aim:
To study NMR measurements for detection of adulter-
ation of spreadable fats.
Partners:
• Universität für Bodenkultur (A); Bundesanstalt für
Milchforschung (D); Unilever Nederland BV (NL);
Mylnefield Research Services LTD (UK)
PICADA
Aim:
To test the photo-catalytic activity of TiO2, added to
different building materials (concrete etc.) for its
ability to induce degradation of inorganic (NO, NO2,
O3) and organic compounds (VOCs).
Partners:
• Italcementi Group - Bergamo (I); University of Thes-
saloniki (GR)
INDEX
Aim:
To create a network of European scientists in the area
of indoor air pollution and the herewith-associated
health impacts.
Partners:
• Federal Environmental Agency Germany (UBA); Na-
tional Institute for Health (KTL Kuopio, FIN); Uni-
versity of Aarhus (DK); Ospedale Luigi Sacco (I);
Department of Psychology Stockholm University
(S); Sustainable Development Department, Health
and Building Division (F); University of Athens En-
ergy Physics Department (Gr); University College
Dublin (IRL)
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QASUME
Aim:
The development of a new approach for facilitating
Quality Assurance of solar ultraviolet spectral irradi-
ance measurements presently carried out in Europe.
In this frame a transportable Unit, developed and
hosted at the PCE Unit, which, after thorough testing
and validation, will be visiting European UV stations
to acquire spectral measurements of global solar irra-
diance that will be compared with those of the local
spectroradiometers.
Partners:
• Laboratory of Atmospheric Physics, Aristotle Uni-
versity of Thessaloniki (GR); University of Inns-
bruck (A); University of Manchester, Institute of
Science & Technology (UK); Institute for Meteoro-
logy and Climatology, University of Hannover (D);
National Institute for Public Health and the Envi-
ronment (RIVM) (NL); Finnish Meteorological Insti-
tute (FIN).
EDUCE
Aim:
To investigate the ultraviolet (UV) radiation climate
in Europe.
Partners:
• Institute for Meteorology and Climatology, Univer-
sity of Hannover (D); Norwegian University of Sci-
ence and Technology; Institute for Geophysics, As-
trophysics and Meteorology, University of Graz (A);
Finnish Meteorological Institute; British Antarctic
Survey; Laboratory of Atmospheric Physics, Aristo-
tle University of Thessaloniki (GR); National Insti-
tute of Public Health and the Environment (NL);
University of Manchester Institute of Science &
Technology (UK); University of Innsbruck (A); Solar
and Ozone Observatory - Czech Hydrometeorologi-
cal Institute (CZ); Institute of Geophysics - Polish
Academy of Sciences (PL); Tartu Observatory (Esto-
nia) (non-exhaustive list)
BMS
BIOGRAD
Aim:
Increasing the performance of total hip replacement
prostheses through high functionally graded mate-
rial innovation and design.
Partners:
• Lima Lto (I); Ceramtec (D); HIP Bodycote (UK);
University of Leuven (B); Helsinki University of
Technology (FIN); LEMI (F); Josef Stefan Institute
(SLO); Nuclear Physics Institute (CZ)
EVIGeM (virtual Institute)
Aim:
The European Virtual Institute of Geometry Measure-
ment (EVIGeM) consists of a linked group of European
partners, committed to assist and help members and
any external customer on all kind of problems con-
cerning geometry measurements.
Partners:
• BIBA (D); Knapp (CH); Mahr (D); Unimetrik (E)
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MEDPHOT
Aim:
Use of optical Methods for Medical Diagnosis and
monitoring of diseases.
Partners:
• ISIS Optronics GmbH (D); R. Wolf GmbH, Storz (D)
• Forth-Isel (GR); PTB-National Metrology Institute
of Germany, Lund Laser Centre (D)
• ILM-University of Ulm; Robert-Rossle Hospital-
Berlin, Humboldt University; MLL-University, Lu-
beck (F); Storz (D)
• Università L’ Aquila (I); Univerity of Paris XIII (F);
University of Twente (NL)
• AMC, Laser Centre (NL); Politecnico di Milano -
POLIMI (I); Academisch Ziekenhuis Rotterdam
(NL); ICSTM- Imperial College (UK)
PLASMATECH
Aim:
The PLASMATECH network intends to co-ordinate Eu-
ropean activities in the field of Plasma Technologies
in order to develop and apply them to the domains of
Textile, Health, Food and Environment. In particular,
its main objectives are to concentrate all the RTD ac-
tivities on plasma technologies scattered in EU zone
and at a development stage, to promote knowledge
transfers, discussion and exchange of information in
the consortium, to monitor the production of scien-
tific advice world-wide, to conceive and evaluate po-
tential new niche applications with added value, to
generate new developments through projects con-
tracted between partners, and to share knowledge
leading to best practice and new standards. The Plas-
matech network contains 47 partners from 12 differ-
ent countries distributed equally in the four fields of
interest.
Partners:
• Institut Français du Textile et de l’Habillement
(IFTH) (F); Nodal Consultants (F); Dow Corning
Plasma Solutions (IRL); Fraunhofer Institute for
Manufacturing and Advanced Materials (IFAM) (D);
IFP Research AB (S); University of Durham (UK); El-
tro GmbH (D); Europlasma N.V. (B); Axcys Technolo-
gies (F); Industrias Texteis Somelos SA (P);
Chargeurs Group CREAT (F); Saati Print (I); Bio-
matech SA (F); Università di Bari - Dipartimento di
Chimica (I); University of Jena - Institute of Mate-
rial Science (D); Università di Catania - Dipartimen-
to di Scienze Chimiche (I); CSM Instruments (CH);
LCC Engineering & Trading GmbH (CH); Arjo Wiggins
(F); Metec Tecnologie Snc (I); CSMA Limited (UK);
Absys (F); Robert Bosch GmbH (D); Université
Pierre et Marie Curie - École Nationale Supèrieure de
Chimie de Paris (ENSCP) (F); University of Bochum
(D); University of Stuttgart - Institut für Plasmafor-
schung (D); Consejo Superior de Investigaciones
Científicas (CSIC) - Instituto de Ciencia de Mate-
riales de Sevilla (E); Biophy Research (F); MAT Plas-
MATec GmbH (D); Sidel (F); Tetrapak (CH); Environ-
ment Park (I); Institut für Niedertemperatur – Plas-
maphysik (INP) (D); Centro Ricerche Fiat (I);
Advanced Energy Industries GmbH (D); Charles Uni-
versity (CZ); University of Patras (GR); Aixtron AG
(D); Air Liquide (F); Renault (F); Plasma Air AG (D);
Laboratoire de Physique des Gaz et des Plasmas
LPGP – CNRS (F); EDF (F); Muegge Electronic GmbH
(D); Plasso Technology (UK); University of Milan Bi-
cocca (I).
STERIPLAS
Aim:
Study and validation of an advanced plasma sterilisa-
tion process.
Partners:
• Arjo Wiggins (F); R. Bosch GmbH (D); Metal Process
(F); Biomatech S.A. (F); C.I.R.M. (I)
IFCA
Aim:
Immunoprobes for Food Contamination Analysis (IFCA).
Partners:
• École Nationale Supérieure de Chimie de Paris (F);
Universidad de Vigo (E); Innosense SpA (I); LCC
(CH); Abkem (ES); CSMA (UK)
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LAPLADIS
Aim:
Large Area Plasma Etching Process for Display Appli-
cations.
Partners:
• FIAT (I); THOMSOM (F); FHR (D); EUROINKS (I)
Structural Monitoring of the Duomo of Como
using Optical Fibre Bragg Grating Sensors
Aim:
To install a remote automated monitoring system and
a network of sensors (~1000m of optical cable) based
on optical fibre Bragg gratings for continuous meas-
urement of temperature and relative displacement. A
data report file is sent by email every day. The raw da-
ta are entered in a database, transformed into tables
and diagrams in order to display the structural status
of the cathedral, and made accessible on internet to
authorised persons to be exploited by engineers and
decision makers.
Partners:
• Comitato per la Salvaguardia del Duomo di Como,
Amministrazione Provinciale di Como (I); Politec-
nico di Milano (I).
SPOTS
Aim:
Standardisation Project for Optical Techniques of Strain
Measurement.
Partners:
• University of Sheffield (UK); Optical Metrology Inno-
vations (IRL); Ettemeyer AG (D); NPL Management
Ltd (UK); SNECMA Moteurs (F); Honlet Optical Sys-
tems GMBH (D); Politechnika Warszawska (PL); CRF
Società Consortile per Azioni (I); Eidgenössische Ma-
terialprüfungs- und Forschungsanstalt (CH)
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